Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Dr. med. Lisa Zimmer

Funktionen

  • Oberarzt/-ärztin, Klinik für Dermatologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Mo, Jeremy; Zaremba-Montenari, Anne; Inderjeeth, Andrisha-Jade; El Zeinaty, Perla; Li, Ao; Wicky, Alexandre; Della Marta, Nicholas; Marqueste, Caroline Gaudy; Bohne, Ann-Sophie; Matias, Margarida; McNamee, Nicholas; Festino, Lucia; Chen, Charley; Ch'ng, Sydney; van Akkooi, Alexander C.J.; Meda, Laetitia Da; Park, John J.; Ascierto, Paolo A.; Hauschild, Axel; Lee, Jenny H.; Grob, Jean Jacques; Mangana, Joanna; Guminski, Alex; Michielin, Olivier; Xu, Wen; Lebbe, Celeste; Sandhu, Shahneen; Zimmer, Lisa; Menzies, Alexander M.; Lo, Serigne N.; Long, Georgina V.; Carlino, Matteo S.; da Silva, Ines Pires
    Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma
    In: European Journal of Cancer (EJC) , Jg. 217 2025, 115254
    DOI
  • Borys, Katarzyna; Lodde, Georg; Livingstone, Elisabeth; Weishaupt, Carsten; Römer, Christian; Künnemann, Marc-David; Helfen, Anne; Zimmer, Lisa; Galetzka, Wolfgang; Haubold, Johannes; Friedrich, Christoph M.; Umutlu, Lale; Heindel, Walter; Schadendorf, Dirk; Hosch, René; Nensa, Felix
    Correction : Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
    In: Journal of Translational Medicine , Jg. 23 2025, Nr. 1, 596
    DOI (Open Access)
  • Livingstone, Elisabeth; Gogas, H.J.; Kandolf, L.; Meier, F.; Eigentler, T.K.; Ziemer, M.; Terheyden, P.; Gesierich, A.; Herbst, R.A.; Kähler, K.C.; Ziogas, D.C.; Mijušković, Ž.; Garzarolli, M.; Garbe, C.; Rösch, Alexander; Ugurel, Selma; Gutzmer, R.; Gaudy-Marqueste, C.; Kiecker, F.; Utikal, J.; Hartmann, M.; Miethe, S.; Eckhardt, S.; Zimmer, Lisa; Schadendorf, Dirk
    Early switch from run-in with targeted to immunotherapy in advanced BRAFV⁶⁰⁰-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial
    In: ESMO Open , Jg. 10 2025, Nr. 5, 105053
    DOI (Open Access)
  • Tomsitz, Dirk; Livingstone, Elisabeth; Loquai, Carmen; Kaatz, Martin; Leiter, Ulrike; Schilling, Bastian; Terheyden, Patrick; Hassel, Jessica; Sachse, Michael; Ulrich, Jens; Dippel, Edgar; Meiss, Frank; Pföhler, Claudia; Kreuter, Alexander; Herbst, Rudolf; Weichenthal, Michael; Zimmer, Lisa; Meier, Friedegund; Rauschenberg, Ricarda; Mohr, Peter; Brunnert, Fiona; von Wasielewski, Imke; Gutzmer, Ralf; Schadendorf, Dirk; Berking, Carola; Ugurel, Selma; Heinzerling, Lucie
    Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma
    In: Journal of the European Academy of Dermatology and Venereology 2025 , in press
    DOI (Open Access)
  • Borys, Katarzyna; Lodde, Georg; Livingstone, Elisabeth; Weishaupt, Carsten; Römer, Christian; Künnemann, Marc-David; Helfen, Anne; Zimmer, Lisa; Galetzka, Wolfgang; Haubold, Johannes; Friedrich, Christoph M.; Umutlu, Lale; Heindel, Walter; Schadendorf, Dirk; Hosch, René; Nensa, Felix
    Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
    In: Journal of Translational Medicine , Jg. 23 2025, Nr. 1, 532
    DOI (Open Access)
  • Kött, Julian; Zell, Tim; Zimmermann, Noah; Rünger, Alessandra; Smit, Daniel J.; Abeck, Finn; Geidel, Glenn; Hansen-Abeck, Inga; Heidrich, Isabel; Weichenthal, Michael; Ugurel, Selma; Leiter, Ulrike; Berking, Carola; Gutzmer, Ralf; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth; von Wasielewski, Imke; Mohr, Peter; Meier, Friedegund; Haferkamp, Sebastian; Drexler, Konstantin; Herbst, Rudolf; Kellner, Ivonne; Utikal, Jochen; Wohlfeil, Sebastian A.; Pföhler, Claudia; Adam, Leonie; Terheyden, Patrick; Ulrich, Jens; Meiss, Frank; Möbes, Monica; Welzel, Julia; Schilling, Bastian; Ziller, Fabian; Kaatz, Martin; Kreuter, Alexander; Sindrilaru, Anca; Dippel, Edgar; Sachse, Michael; Weishaupt, Carsten; Hüning, Svea; Heinzerling, Lucie; Loquai, Carmen; Schley, Gaston; Gambichler, Thilo; Löffler, Harald; Grabbe, Stephan; Schultz, Erwin; Devereux, Nina; Hassel, Jesscia C.; Simon, Jan-Ch.; Raap, Ulrike; Assaf, Chalid; Klemke, Claus-Detlev; Sunderkötter, Cord; Hofmann, Silke C.; Wenk, Saskia; Tronnier, Michael; Thies, Silke; Heppt, Markus V.; Eggermont, Alexander; Schulze, Hans-Joachim; Zouboulis, Christos C.; Tüting, Thomas; Bauer, Alexander T.; Schneider, Stefan W.; Gebhardt, Christoffer
    Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy : A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg
    In: European Journal of Cancer (EJC) , Jg. 214 2025, 115159
    DOI (Open Access)
  • Handel, Eleanor E.; McKeown, Janet; Wei, Joe; Kankaria, Roma A.; Burnette, Hannah; Johnson, Douglas B.; Lawless, Aleigha; Czapla, Juliane; Sullivan, Ryan J.; Albrecht, Jessica Lea; Zimmer, Lisa; Mangana, Joanna; Dummer, Reinhard; Kessels, Jolien I.; Neyns, Bart; Allayous, Clara; Lebbe, Celeste; Boatwright, Christina; Mehnert, Janice M.; Ottaviano, Margaret; Ascierto, Paolo A.; Czarnecka, Anna M.; Rutkowski, Piotr; Lo, Serigne N.; Long, Georgina V.; Menzies, Alexander M.; Carlino, Matteo S.
    Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma
    In: European Journal of Cancer (EJC) , Jg. 215 2025, 115171
    DOI
  • Placke, Jan-Malte; Rajcsanyi, Luisa Sophie; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Weichenthal, Michael; Meier, Friedegund; Berking, Carola; Leiter, Ulrike; Seier, Johanna; Krefting, Frederik; Tasdogan, Alpaslan; Lodde, Georg; Livingstone, Elisabeth; Zimmer, Lisa; Rösch, Alexander; Griewank, Klaus; Schadendorf, Dirk; Ugurel, Selma
    Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status
    In: Frontiers in Immunology , Jg. 16 2025, 1536642
    DOI (Open Access)
  • Reitmajer, Markus; Livingstone, Elisabeth; Thoms, Kai-Martin; Heppt, Markus V.; Meiss, Frank; Gesierich, Anja; Drexler, Konstantin; Heinzerling, Lucie; Meier, Friedegund; Menzer, Christian; Schlaak, Max; Zimmer, Lisa; Forschner, Andrea
    Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 23 2025, Nr. 3, S. 321 – 327
    DOI (Open Access)
  • Reitmajer, Markus; Livingstone, Elisabeth; Thoms, Kai‐Martin; Heppt, Markus V.; Meiss, Frank; Gesierich, Anja; Drexler, Konstantin; Heinzerling, Lucie; Meier, Friedegund; Menzer, Christian; Schlaak, Max; Zimmer, Lisa; Forschner, Andrea
    Real‐world management bei Patienten mit Komplettremission unter Immuncheckpoint‐Inhibition bei fortgeschrittenem Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 23 2025, Nr. 3, S. 321 – 329
    DOI (Open Access)
  • Jansen, Philipp; Galetzka, Wolfgang; Thielmann, Carl Maximilian; Murali, Rajmohan; Zaremba-Montenari, Anne; Standl, Fabian; Lodde, Georg; Möller, Inga; Sucker, Antje; Paschen, Annette; Hadaschik, Eva; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Stang, Andreas; Griewank, Klaus
    pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy
    In: European Journal of Cancer (EJC) , Jg. 220 2025, 115337
    DOI (Open Access)
  • Albrecht, Jessica Lea; Dimitriou, Florentia; Grover, Piyush; Hassel, Jessica C.; Erdmann, Michael; Forschner, Andrea; Johnson, Douglas B.; Váraljai, Renáta; Lodde, Georg; Placke, Jan-Malte; Krefting, Frederik; Zaremba, Anne; Ugurel, Selma; Rösch, Alexander; Schulz, Carsten; Berking, Carola; Pöttgen, Christoph; Menzies, Alexander M.; Long, Georgina V.; Dummer, Reinhard; Livingstone, Elisabeth; Schadendorf, Dirk; Zimmer, Lisa
    Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
    In: European Journal of Cancer (EJC) , Jg. 202 2024, 113976
    DOI (Open Access)
  • Chorti, Eleftheria; Kowall, Bernd; Hassel, Jessica C.; Schilling, Bastian; Sachse, Michael; Gutzmer, Ralf; Loquai, Carmen; Kähler, Katharina C.; Hüsing, Anika; Gilde, Catharina; Thielmann, Carl Maximilian; Zaremba-Montenari, Anne; Placke, Jan-Malte; Gratsias, Emmanouil; Martaki, Anna; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Stang, Andreas; Zimmer, Lisa
    Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade
    In: European Journal of Cancer (EJC) , Jg. 200 2024, 113536
    DOI (Open Access)
  • Krueger, Oskar; Eisenburger, Robin; Tasdogan, Alpaslan; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Theurer, Sarah; Brodin, Berthold; Schadendorf, Dirk; Ugurel, Selma
    Case report: : Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab
    In: Frontiers in Immunology , Jg. 15 2024, 1369190
    DOI, Online Volltext (Open Access)
  • Matull, Johanna; Placke, Jan-Malte; Lodde, Georg; Zaremba-Montenari, Anne; Utikal, Jochen; Terheyden, Patrick; Pföhler, Claudia; Herbst, Rudolf; Kreuter, Alexander; Welzel, Julia; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Thielmann, Carl Maximilian; Griewank, Klaus
    Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
    In: Frontiers in Immunology , Jg. 15 2024, 1383125
    DOI (Open Access)
  • Lodde, Georg; Zhao, Fang; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Jansen, Philipp; Kowall, Bernd; Galetzka, Wolfgang; Hörst, Fabian; Kleesiek, Jens; Hellwig, Birte; Rahnenführer, Jörg; Rajcsanyi, Luisa; Peters, Triinu; Hinney, Anke; Placke, Jan-Malte; Sucker, Antje; Paschen, Annette; Becker, Jürgen; Livingstone, Elisabeth; Zimmer, Lisa; Tasdogan, Alpaslan; Rösch, Alexander; Hadaschik, Eva; Schadendorf, Dirk; Griewank, Klaus; Ugurel, Selma
    Early versus late response to PD-1-based immunotherapy in metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 210 2024, 114295
    DOI (Open Access)
  • Kochanek, Corinna; Gilde, Catharina; Zimmer, Lisa; Ugurel, Selma; Meier, Friedegund; Utikal, Jochen; Pföhler, Claudia; Herbst, Rudolf; Haferkamp, Sebastian; Welzel, Julia; Dücker, Pia; Leiter, Ulrike; Weichenthal, Michael; von Wasielewski, Imke; Angela, Yenny; Gutzmer, Ralf
    Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma : An analysis of the prospective skin cancer registry ADOREG
    In: European Journal of Cancer (EJC) , Jg. 198 2024, 113508
    DOI (Open Access)
  • Taylor, Amelia M.; McKeown, Janet; Dimitriou, Florentia; Jacques, Sarah K.; Zimmer, Lisa; Allayous, Clara; Yeoh, Hui-Ling; Haydon, Andrew; Ressler, Julia M.; Galea, Claire; Woodford, Rachel; Kahler, Katharina; Hauschild, Axel; Festino, Lucia; Hoeller, Christoph; Schwarze, Julia K.; Neyns, Bart; Wicky, Alexandre; Michielin, Olivier; Placzke, Joanna; Rutkowski, Piotr; Johnson, Douglas B.; Lebbe, Celeste; Dummer, Reinhard; Ascierto, Paolo A.; Lo, Serigne; Long, Georgina V.; Carlino, Matteo S.; Menzies, Alexander M.
    Efficacy and safety of ‘Second Adjuvant’ therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
    In: European Journal of Cancer (EJC) , Jg. 199 2024, 113561
    DOI
  • Tarantino, Giuseppe; Ricker, Cora A.; Wang, Annette; Ge, William; Aprati, Tyler J.; Huang, Amy Y.; Madha, Shariq; Chen, Jiajia; Shi, Yingxiao; Glettig, Marc; Feng, Catherine H.; Frederick, Dennie T.; Freeman, Samuel; Holovatska, Marta M.; Manos, Michael P.; Zimmer, Lisa; Rösch, Alexander; Zaremba, Anne; Livingstone, Elisabeth; Jameson, Jacob C.; Saghafian, Soroush; Lee, Andrew; Zhao, Karena; Morris, Luc G.T.; Reardon, Brendan; Park, Jihye; Elmarakeby, Haitham A.; Schilling, Bastian; Giobbie-Hurder, Anita; Vokes, Natalie I.; Buchbinder, Elizabeth I.; Flaherty, Keith T.; Haq, Rizwan; Wu, Catherine J.; Boland, Genevieve M.; Hodi, F. Stephen; Van Allen, Eliezer M.; Schadendorf, Dirk; Liu, David
    Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
    In: Science Advances , Jg. 10 2024, Nr. 48, eadp4670
    DOI (Open Access)
  • Wohlfeil, Sebastian A.; Kranzmann, Leonie; Weiß, Christel; von Wasielewski, Imke; Klespe, Kai C.; Kähler, Katharina C.; Weichenthal, Michael; Schadendorf, Dirk; Zimmer, Lisa; Mohr, Peter; Meier, Friedegund; Pfoehler, Claudia; Berking, Carola; Heppt, Markus V.; Herbst, Rudolf; Kreuter, Alexander; Gutzmer, Ralf; Ulrich, Jens; Meiss, Frank; Gebhardt, Christoffer; Dippel, Edgar; Leiter, Ulrike; Schilling, Bastian; Ugurel, Selma; Utikal, Jochen
    Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma : A multicenter study on 1383 patients of the prospective DeCOG registry ADOReg
    In: International Journal of Cancer , Jg. 155 2024, Nr. 10, S. 1808 – 1823
    DOI (Open Access)
  • Harvey, Catriona; Nahar, Kazi J; McKeown, Janet; Lo, Serigne N; Farag, Sheima; Yousaf, Nadia; Young, Kate; Tas, Liselotte; Meerveld-Eggink, Aafke; Blank, Christian; Thomas, Austin; McQuade, Jennifer; Schilling, Bastian; Johnson, Douglas B; Huertas, Roberto Martín; Arance, Ana; Lee, Joanna; Zimmer, Lisa; Long, Georgina V; Carlino, Matteo S; Wang, Yinghong; Menzies, Alexander Maxwell
    Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity : a multicenter case series
    In: Journal for ImmunoTherapy of Cancer , Jg. 12 2024, Nr. 1, e008232
    DOI (Open Access)
  • Hassel, Jessica C.; Zimmer, Lisa
    Nebenwirkungen dermatoonkologischer Therapien : Side effects of dermato-oncologic therapies
    In: Die Dermatologie , Jg. 75 2024, S. 466 – 475
    DOI
  • Zimmer, Lisa; Hassel, Jessica C.
    Nebenwirkungen onkologischer Therapien
    In: Die Dermatologie , Jg. 75 2024, Nr. 6, S. 437 – 439
    DOI (Open Access)
  • Jacques, Sarah K.; McKeown, Janet; Grover, Piyush; Johnson, Douglas B.; Zaremba-Montenari, Anne; Dimitriou, Florentia; Weiser, Roi; Farid, Mohamad; Namikawa, Kenjiro; Sullivan, Ryan J.; Rutkowski, Piotr; Lebbe, Celeste; Hamid, Omid; Zager, Jonathan S.; Michielin, Olivier; Neyns, Bart; Nakamura, Yasuhiro; Robert, Caroline; Mehnert, Janice; Ascierto, Paolo A.; Bhave, Prachi; Park, Benjamin; Zimmer, Lisa; Mangana, Joanna; Mooradian, Megan; Placzke, Joanna; Allayous, Clare; Glitza Oliva, Isabella C.; Mehmi, Inderjit; Depalo, Danielle; Wicky, Alexandre; Schwarze, Julia K.; Roy, Severine; Boatwright, Christina; Vanella, Vito; Long, Georgina V.; Menzies, Alexander M.; Lo, Serigne N.; Carlino, Matteo S.
    Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
    In: European Journal of Cancer (EJC) , Jg. 199 2024, 113563
    DOI
  • Ruf, Theresa; Kramer, Rafaela; Forschner, Andrea; Leiter, Ulrike; Meier, Friedegund; Reinhardt, Lydia; Dücker, Pia; Ertl, Carolin; Tomsitz, Dirk; Tietze, Julia K.; Gutzmer, Ralf; Dabrowski, Evelyn; Zimmer, Lisa; Gesierich, Anja; Zierold, Sarah; French, Lars E.; Eigentler, Thomas; Amaral, Teresa; Heinzerling, Lucie
    Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors
    In: European Journal of Cancer (EJC) , Jg. 203 2024, 114028
    DOI (Open Access)
  • Jansen, Philipp; Galetzka, Wolfgang; Lodde, Georg; Standl, Fabian; Zaremba-Montenari, Anne; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Placke, Jan-Malte; Landsberg, Jennifer; Möller, Inga; Sucker, Antje; Paschen, Annette; Hadaschik, Eva; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Stang, Andreas; Griewank, Klaus
    Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas
    In: European Journal of Cancer (EJC) , Jg. 208 2024, 114208
    DOI (Open Access)
  • Wang, Ying; Ertl, Carolin; Schmitt, Christina; Hammann, Linda; Kramer, Rafaela; Grabmaier, Ulrich; Schöberl, Florian; Anz, David; Piseddu, Ignazio; Pesch, Giulia; Vera, Julio; Froehlich, Waltraud; Weckbach, Ludwig; Tomsitz, Dirk; Loquai, Carmen; Zimmer, Lisa; Mangana, Johanna; Dummer, Reinhard; Gutzmer, Ralf; Klespe, Kai-Christian; Stege, Henner; Meiss, Frank; Thoms, Kai-Martin; Terheyden, Patrick; Bröckelmann, Paul J.; Johnson, Douglas B.; French, Lars E.; Heinzerling, Lucie
    Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
    In: Frontiers in Cardiovascular Medicine , Jg. 11 2024, 1408586
    DOI (Open Access)
  • Schaper-Gerhardt, Katrin; Gutzmer, Ralf; Angela, Yenny; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Hassel, Jessica C.; Weishaupt, Carsten; Remes, Bernhard; Kubat, Linda; Spassova, Ivelina; Becker, Jürgen
    The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
    In: European Journal of Cancer (EJC) , Jg. 202 2024, 113984
    DOI (Open Access)
  • Hepner, Adriana; Versluis, Judith M.; Wallace, Roslyn; Allayous, Clara; Brown, Lauren Julia; Trojaniello, Claudia; Gerard, Camille Lea; Jansen, Yanina Jeanne Leona; Bhave, Prachi; Neyns, Bart; Haydon, Andrew; Michielin, Olivier; Mangana, Joanna; Klein, Oliver; Shoushtari, Alexander N.; Warner, Allison Betof; Ascierto, Paolo Antonio; McQuade, Jennifer Leigh; Carlino, Matteo S.; Zimmer, Lisa; Lebbe, Celeste; Johnson, Douglas B.; Sandhu, Shahneen; Atkinson, Victoria; Blank, Christian U.; Lo, Serigne N.; Long, Georgina V.; Menzies, Alexander M.
    The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 196 2024, 113441
    DOI
  • Ertl, Carolin; Ruf, Theresa; Mentzer, Dirk; Kong, Mingzi; Kramer, Rafaela; Bergwelt-Baildon, Michael von; Subklewe, Marion; Tomsitz, Dirk; Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen; Lebbé, Celeste; Long, Georgina V.; McArthur, Grant; Neilan, Tomas G.; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Zimmer, Lisa; Eigentler, Thomas; Grabbe, Stephan; Forschner, Andrea; Kähler, Katharina C.; Milani, Valeria; Pföhler, Claudia; Hassel, Jessica; Gutzmer, Ralf; Loquai, Carmen; Routy, Bertrand; Furness, Andrew J.S.; Blank, Christian; Wolchok, Jedd D.; French, Lars E.; Hauschild, Axel; Heinzerling, Lucie
    The side effect registry immuno-oncology (SERIO) : A tool for systematic analysis of immunotherapy-induced side effects
    In: European Journal of Cancer (EJC) , Jg. 199 2024, 113505
    DOI
  • Becker, Jürgen; Ugurel, Selma; Leiter, Ulrike; Meier, Friedegund; Gutzmer, Ralf; Haferkamp, Sebastian; Zimmer, Lisa; Livingstone, Elisabeth; Eigentler, Thomas K; Hauschild, Axel; Kiecker, Felix; Hassel, Jessica C; Mohr, Peter; Fluck, Michael; Thomas, Ioannis; Garzarolli, Marlene; Grimmelmann, Imke; Drexler, Konstantin; Spillner, Alexandra N; Eckhardt, Sebastian; Schadendorf, Dirk; van Akkoi, Alexander; van Houdt, Winan; Wilhelm, Tabea; Farmer, Kimberly; Ulrich, Claas; Gambichler, Thilo; Bluhm, Leonie; Schinagl, Heidemarie; Kellner, Ivonne; Herbst, Rudolf; Meiß, Frank; Rafei-Shamsabadi, David; Sell, Sabine; Kaatz, Martin; Wulfken, Lena; Hartmann, Martin; Kähler, Katharina; Ziemer, Mirjana; Simon, Jan; Terheyden, Patrick; Thaci, Diamant; Loquai, Carmen; Mitzel-Rink, Heidrun; Grabbe, Stephan; Stege, Henner; Gaiser, Maria; Utikal, Jochen; Berking, Carola; Heinzerling, Lucie; Schlaak, Max; Tomsitz, Dirk; Dyballa, Jörg; Magnolo, Nina; Weishaupt, Carsten; Berneburg, Mark; Garbe, Claus; Flatz, Lukas; Gesierich, Anja; Schilling, Bastian
    Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O) : disease-free survival results from a randomised, open-label, phase 2 trial
    In: Lancet , Jg. 402 2023, Nr. 10404, S. 798 – 808
    DOI
  • Lodde, Georg; Hassel, Jessica; Wulfken, Lena M.; Meier, Friedegund; Mohr, Peter; Kähler, Katharina; Hauschild, Axel; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Beckmann, Catharina L.; Stang, Andreas; Kowall, Bernd; Galetzka, Wolfgang; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Forschner, Andrea; Livingstone, Elisabeth
    Adjuvant treatment and outcome of stage III melanoma patients : Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study
    In: European Journal of Cancer (EJC) , Jg. 191 2023, 112957
    DOI
  • Váraljai, Renáta; Zimmer, Lisa; Al-Matary, Yahya; Kaptein, Paulien; Albrecht, Lea J.; Shannan, Batool; Brase, Jan C.; Gusenleitner, Daniel; Amaral, Teresa; Wyss, Nina; Utikal, Jochen; Flatz, Lukas; Rambow, Florian; Reinhardt, Hans Christian; Dick, Jenny; Engel, Daniel R.; Horn, Susanne; Ugurel, Selma; Sondermann, Wiebke; Livingstone, Elisabeth; Sucker, Antje; Paschen, Annette; Zhao, Fang; Placke, Jan M.; Klose, Jasmin M.; Fendler, Wolfgang P.; Thommen, Daniela S.; Helfrich, Iris; Schadendorf, Dirk; Rösch, Alexander
    Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
    In: Nature Cancer , Jg. 4 2023, Nr. 9, S. 1395
    DOI (Open Access)
  • Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Kähler, Katharina; Grimmelmann, Imke; Gutzmer, Ralf; Utikal, Jochen; Terheyden, Patrick; Herbst, Rudolf; Haferkamp, Sebastian; Pfoehler, Claudia; Forschner, Andrea; Leiter, Ulrike; Ziller, Fabian; Meiss, Frank; Ulrich, Jens; Kreuter, Alexander; Gebhardt, Christoffer; Welzel, Julia; Schilling, Bastian; Kaatz, Martin; Scharfetter-Kochanek, Karin; Dippel, Edgar; Nashan, Dorothee; Sachse, Michael; Weishaupt, Carsten; Löffler, Harald; Gambichler, Thilo; Loquai, Carmen; Heinzerling, Lucie; Grabbe, Stephan; Debus, Dirk; Schley, Gaston; Hassel, Jessica C.; Weyandt, Gerhard; Trommer, Maike; Lodde, Georg; Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen Christian; Horn, Susanne; Schadendorf, Dirk; Ugurel, Selma
    Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer , Jg. 11 2023, Nr. 4
    DOI (Open Access)
  • Lodde, Georg C.; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Sucker, Antje; Placke, Jan-Malte; Zaremba, Anne; Albrecht, Lea Jessica; Kowall, Bernd; Galetzka, Wolfgang; Becker, Jürgen C.; Tasdogan, Alpaslan; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma; Griewank, Klaus
    Characterisation and outcome of RAC1 mutated melanoma
    In: European Journal of Cancer (EJC) , Jg. 183 2023, S. 1 – 10
    DOI
  • Placke, Jan-Malte; Kimmig, Mona; Griewank, Klaus; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Welzel, Julia; Engel, Daniel Robert; Kreft, Sophia; Sucker, Antje; Lodde, Georg; Krefting, Frederik; Stoffels, Ingo; Klode, Joachim; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Becker, Jürgen; Weichenthal, Michael; Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel, Selma
    Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma ADOREG/TRIM : Analysis of the DeCOG prospective multicenter cohort study
    In: eBioMedicine , Jg. 96 2023, 104774
    DOI (Open Access)
  • Livingstone, Elisabeth; Gogas, H.; Kandolf-Sekulovic, L.; Meier, F.; Eigentler, T.K.; Ziemer, M.; Terheyden, P.A.M.; Gesierich, A.H.; Herbst, R.A.; Kähler, K.C.; Ziogas, D.C.; Mijuskovic, Z.; Garzarolli, M.; Garbe, C.; Rösch, Alexander; Ugurel, Selma; Gutzmer, R.; Grob, J.J.; Kiecker, F.; Utikal, J.; Windemuth-Kieselbach, C.; Eckhardt, S.; Zimmer, Lisa; Schadendorf, Dirk
    Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma : The ImmunoCobiVem phase 2 randomised trial
    In: European Journal of Cancer (EJC) , Jg. 190 2023, 112941
    DOI
  • Wong, Selina K.; Blum, Steven M.; Sun, Xiaopeng; Da Silva, Inês P.; Zubiri, Leyre; Ye, Fei; Bai, Kun; Zhang, Kevin; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Serra-Bellver, Patricio; Muñoz-Couselo, Eva; Ortiz, Carolina; Lostes, Julia; Huertas, Roberto M.; Arance, Ana; Pickering, Lisa; Long, Georgina V.; Carlino, Matteo S.; Buchbinder, Elizabeth I.; Vázquez-Cortés, Leticia; Jara-Casas, Diego; Márquez-Rodas, Iván; González-Espinoza, Iván R.; Balko, Justin M.; Menzies, Alexander M.; Sullivan, Ryan J.; Johnson, Douglas B.
    Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 181 2023, S. 188 – 197
    DOI
  • Lai-Kwon, Julia; Jacques, Sarah; Carlino, Matteo; Benannoune, Naima; Robert, Caroline; Allayous, Clara; Baroudjian, Barouyr; Lebbe, Celeste; Zimmer, Lisa; Eroglu, Zeynep; Topcu, Turkan Ozturk; Dimitriou, Florentia; Haydon, Andrew; Lo, Serigne N.; Menzies, Alexander M.; Long, Georgina V.
    Efficacy of ipilimumab 3 mg/kg following progression on low-dose ipilimumab in metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 186 2023, S. 12 – 21
    DOI
  • Zaremba, Anne; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Pföhler, Claudia; Weichenthal, Michael; Terheyden, Patrick; Forschner, Andrea; Leiter, Ulrike; Ulrich, Jens; Utikal, Jochen; Welzel, Julia; Kaatz, Martin; Gebhardt, Christoffer; Herbst, Rudolf; Sindrilaru, Anca; Dippel, Edgar; Sachse, Michael; Meiss, Frank; Heinzerling, Lucie; Haferkamp, Sebastian; Weishaupt, Carsten; Löffler, Harald; Kreft, Sophia; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa
    Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma : a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
    In: European Journal of Cancer (EJC) , Jg. 188 2023, S. 140 – 151
    DOI, Online Volltext (Open Access)
  • Nuñez, Nicolas Gonzalo; Berner, Fiamma; Friebel, Ekaterina; Unger, Susanne; Wyss, Nina; Martinez Gomez, Julia; Purde, Mette-Triin; Niederer, Rebekka; Porsch, Maximilian; Lichtensteiger, Christa; Kramer, Rafaela; Erdmann, Michael; Schmitt, Christina; Heinzerling, Lucie; Abdou, Marie-Therese; Karbach, Julia; Schadendorf, Dirk; Zimmer, Lisa; Ugurel, Selma; Klümper, Niklas; Hölzel, Michael; Power, Laura; Kreutmair, Stefanie; Capone, Mariaelena; Madonna, Gabriele; Cevhertas, Lacin; Heider, Anja; Amaral, Teresa; Hasan Ali, Omar; Bomze, David; Dimitriou, Florentia; Diem, Stefan; Ascierto, Paolo Antonio; Dummer, Reinhard; Jäger, Elke; Driessen, Christoph; Levesque, Mitchell Paul; van de Veen, Willem; Joerger, Markus; Früh, Martin; Becher, Burkhard; Flatz, Lukas
    Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
    In: Med , Jg. 4 2023, Nr. 2, S. 113 – 129.e7
    DOI (Open Access)
  • Váraljai, Renáta; Zimmer, Lisa; Al-Matary, Yahya; Kaptein, Paulien; Albrecht, Lea J.; Shannan, Batool; Brase, Jan C.; Gusenleitner, Daniel; Amaral, Teresa; Wyss, Nina; Utikal, Jochen; Flatz, Lukas; Rambow, Florian; Reinhardt, Hans Christian; Dick, Jenny; Engel, Daniel R.; Horn, Susanne; Ugurel, Selma; Sondermann, Wiebke; Livingstone, Elisabeth; Sucker, Antje; Paschen, Annette; Zhao, Fang; Placke, Jan-Malte; Klose, Jasmin M.; Fendler, Wolfgang; Thommen, Daniela S.; Helfrich, Iris; Schadendorf, Dirk; Rösch, Alexander
    Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
    In: Nature Cancer , Jg. 4 2023, Nr. 9, S. 1292 – 1308
    DOI (Open Access)
  • Hassel, Jessica C.; Zimmer, Lisa; Sickmann, Thomas; Eigentler, Thomas K.; Meier, Friedegund; Mohr, Peter; Pukrop, Tobias; Rösch, Alexander; Vordermark, Dirk; Wendl, Christina; Gutzmer, Ralf
    Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition
    In: Cancers , Jg. 15 2023, Nr. 13, 3448
    DOI (Open Access)
  • Forschner, Andrea; Zimmer, Lisa
    Neues ADO-Komitee „Survivorship“
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. 10, S. 1266 – 1267
    DOI (Open Access)
  • Placke, Jan-Malte; Zahn, Maximilian; Zillikens, Hannah; Krefting, Frederik; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Sucker, Antje; Roesch, Alexander; Tasdogan, Alpaslan; Srinivas, Nalini K.; Schadendorf, Dirk; Becker, Jürgen C.; Ugurel, Selma
    Prognostic factors in the primary care of patients with Merkel cell carcinoma : A monocentric cohort study of 108 patients from a tertiary referral centre
    In: JEADV Clinical Practice , Jg. 2 2023, Nr. 4, S. 810 – 818
    DOI, Online Volltext (Open Access)
  • Albrecht, Lea Jessica; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk
    The Latest Option: Nivolumab and Relatlimab in Advanced Melanoma
    In: Current Oncology Reports , Jg. 25 2023, Nr. 6 , :647-657
    DOI (Open Access)
  • Mallardo, Domenico; Woodford, Rachel; Menzies, Alexander M.; Zimmer, Lisa; williamson, Andrew; Ramelyte, Egle; Dimitriou, Florentia; Wicky, Alexandre; Wallace, Roslyn; Mallardo, Mario; Cortellini, Alessio; Budillon, Alfredo; Atkinson, Victoria; Sandhu, Shahneen; Olivier, Michielin; Dummer, Reinhard; Lorigan, Paul; Schadendorf, Dirk; Long, Georgina V.; Simeone, Ester; Ascierto, Paolo A.
    The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
    In: Journal of Translational Medicine , Jg. 21 2023, Nr. 1, 753
    DOI (Open Access)
  • Salzmann, Martin; Wald, Alexander; Stege, Henner; Loquai, Carmen; Zimmer, Lisa; Hayani, Kinan M.; Heinzerling, Lucie; Gutzmer, Ralf; Enk, Alexander H.; Hassel, Jessica C.
    Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch : A Multicenter, Retrospective Study
    In: Cancers , Jg. 15 2023, Nr. 5, 1426
    DOI (Open Access)
  • Haist, Maximilian; Stege, Henner; Rogall, Friederike; Tan, Yuqi; von Wasielewski, Imke; Klespe, Kai Christian; Meier, Friedegund; Mohr, Peter; Kähler, Katharina C.; Weichenthal, Michael; Hauschild, Axel; Schadendorf, Dirk; Ugurel, Selma; Lodde, Georg; Zimmer, Lisa; Gutzmer, Ralf; Debus, Dirk; Schilling, Bastian; Kreuter, Alexander; Ulrich, Jens; Meiss, Frank; Herbst, Rudolf; Forschner, Andrea; Leiter, Ulrike; Pfoehler, Claudia; Kaatz, Martin; Ziller, Fabian; Hassel, Jessica C.; Tronnier, Michael; Sachse, Michael; Dippel, Edgar; Terheyden, Patrick; Berking, Carola; Heppt, Markus V.; Kiecker, Felix; Haferkamp, Sebastian; Gebhardt, Christoffer; Simon, Jan Christoph; Grabbe, Stephan; Loquai, Carmen
    Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy : A multicenter study from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer , Jg. 11 2023, Nr. 9, e007630
    DOI (Open Access)
  • Livingstone, Elisabeth; Zimmer, Lisa; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas K.; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kiecker, Felix; Dippel, Edgar; Rösch, Alexander; Ziemer, Mirjana; Conrad, Beate; Körner, Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus; Becker, Jürgen C.; Schadendorf, Dirk; Simon, Jan-Christoph; Herbst, Rudolf A.; Berking, Carola; Utikal, Jochen; Sell, Sabine; Martens, Uwe M.; Terheyden, Patrick; Stadler, Rudolf
    Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : Final results of a randomised, double-blind, phase 2 trial
    In: Lancet , Jg. 400 2022, Nr. 10358, S. 1117 – 1129
    DOI
  • Lodde, Georg; Fiedler, Melanie; Dittmer, Ulf; Placke, Jan-Malte; Jansen, Philipp; Becker, Jürgen; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Sondermann, Wiebke; Ugurel, Selma
    COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment : A prospective singlecenter study investigating seroconversion rates
    In: Frontiers in Oncology , Jg. 12 2022, 879876
    DOI, Online Volltext (Open Access)
  • Menzies, Alexander M.; da Silva, Ines Pires; Trojaniello, Claudia; Vieu, Elisabeth; Amaria, Rodabe N.; Zimmer, Lisa; Lo, Serigne N.; Burton, Elizabeth M.; Tawbi, Hussein A.; Schadendorf, Dirk; Grob, Jean J.; Ascierto, Paolo A.; Long, Georgina V.; Pires da Silva, Ines
    CTLA-4 Blockade Resistance after Relatlimab and Nivolumab
    In: The New England Journal of Medicine , Jg. 386 2022, Nr. 17, S. 1668 – 1669
    DOI (Open Access)
  • Müller-Jensen, Leonie; Zierold, Sarah; Versluis, Judith M.; Boehmerle, Wolfgang; Huehnchen, Petra; Endres, Matthias; Mohr, Raphael; Compter, Annette; Blank, Christian U.; Hagenacker, Tim; Meier, Friedegund; Reinhardt, Lydia; Gesierich, Anja; Salzmann, Martin; Hassel, Jessica C.; Ugurel, Selma; Zimmer, Lisa; Banks, Patricia; Spain, Lavinia; Soon, Jennifer A.; Enokida, Tomohiro; Tahara, Makoto; Kähler, Katharina C.; Seggewiss-Bernhardt, Ruth; Harvey, Catriona; Long, Georgina V.; Schöberl, Florian; von Baumgarten, Louisa; Hundsberger, Thomas; Schlaak, Max; French, Lars E.; Knauss, Samuel; Heinzerling, Lucie M.
    Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis : A retrospective multicentre cohort study
    In: European Journal of Cancer (EJC) , Jg. 175 2022, S. 224 – 235
    DOI (Open Access)
  • Jansen, Philipp; Lodde, Georg; Wetter, Axel; Welt, Anja; Stuschke, Martin; Dührsen, U.; Stoffels, Ingo; Klode, Joachim; Livingstone, Elisabeth; Zimmer, Lisa; Rösch, Alexander; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Ugurel, Selma
    Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia : divergent outcomes in two men treated with PD-1 inhibitors
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 36 2022, Nr. S1: Anti PD-1 Therapy of Advanced Cutaneous Squamous Cell Carcinoma, S. 41 – 44
    DOI (Open Access)
  • Goldinger, Simone M.; Buder-Bakhaya, Kristina; Lo, Serigne N.; Forschner, Andrea; McKean, Meredith; Zimmer, Lisa; Khoo, Chloe; Dummer, Reinhard; Eroglu, Zeynep; Buchbinder, Elizabeth I.; Ascierto, Paolo A.; Gutzmer, Ralf; Rozeman, Elisa A.; Hoeller, Christoph; Johnson, Douglas B.; Gesierich, Anja; Kölblinger, Peter; Bennannoune, Naima; Cohen, Justine V.; Kähler, Katharina C.; Wilson, Melissa A.; Cebon, Jonathan; Atkinson, Victoria; Smith, Jessica L.; Michielin, Olivier; Long, Georgina V.; Hassel, Jessica C.; Weide, Benjamin; Haydu, Lauren E.; Schadendorf, Dirk; McArthur, Grant; Ott, Patrick A.; Blank, Christian; Robert, Caroline; Sullivan, Ryan; Hauschild, Axel; Carlino, Matteo S.; Garbe, Claus; Davies, Michael A.; Menzies, Alexander M.
    Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma : a retrospective multicentre analysis
    In: European Journal of Cancer (EJC) , Jg. 162 2022, S. 22 – 33
    DOI
  • Albrecht, Lea Jessica; Höwner, Anna; Griewank, Klaus; Lueong, Smiths S.; von Neuhoff, Nils; Horn, Peter; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, Susanne; Siveke, Jens; Schadendorf, Dirk; Váraljai, Renáta; Rösch, Alexander
    Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
    In: Clinical and Translational Medicine , Jg. 12 2022, Nr. 11, e1090
    DOI, Online Volltext (Open Access)
  • Spassova, Ivelina; Ugurel, Selma; Kubat, Linda; Zimmer, Lisa; Terheyden, Patrick; Mohr, Annalena; Björn Andtback, Hannah; Villabona, Lisa; Leiter, Ulrike; Eigentler, Thomas; Loquai, Carmen; Hassel, Jessica C.; Gambichler, Thilo; Haferkamp, Sebastian; Mohr, Peter; Pfoehler, Claudia; Heinzerling, Lucie; Gutzmer, Ralf; Utikal, Jochen S.; Horny, Kai; Schildhaus, Hans-Ulrich; Habermann, Daniel; Hoffmann, Daniel; Schadendorf, Dirk; Becker, Jürgen
    Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 1, e003198
    DOI, Online Volltext (Open Access)
  • Zaremba-Montenari, Anne; Meier, Friedegund; Schlein, Christian; Jansen, Philipp; Lodde, Georg; Song, Mingxia; Kretz, Julia; Möller, Inga; Stadtler, Nadine; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Sucker, Antje; Schadendorf, Dirk; Griewank, Klaus
    Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants
    In: Pigment Cell and Melanoma Research , Jg. 35 2022, Nr. 6, S. 573 – 586
    DOI (Open Access)
  • Müller-Jensen, Leonie; Zierold, Sarah; Versluis, Judith M; Boehmerle, Wolfgang; Huehnchen, Petra; Endres, Matthias; Mohr, Raphael; Compter, Annette; Blank, Christian U; Hagenacker, Tim; Meier, Friedegund; Reinhardt, Lydia; Gesierich, Anja; Salzmann, Martin; Hassel, Jessica C; Ugurel, Selma; Zimmer, Lisa; Banks, Patricia; Spain, Lavinia; Soon, Jennifer A; Enokida, Tomohiro; Tahara, Makoto; Kähler, Katharina C; Seggewiss-Bernhardt, Ruth; Harvey, Catriona; Long, Georgina V; Schöberl, Florian; von Baumgarten, Louisa; Hundsberger, Thomas; Schlaak, Max; French, Lars E; Knauss, Samuel; Heinzerling, Lucie M
    Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis
    In: Data in Brief , Jg. 45 2022, 108649
    DOI (Open Access)
  • Pires da Silva, Ines; Zakria, Danny; Ahmed, Tasnia; Trojanello, Claudia; Dimitriou, Florentia; Allayous, Clara; Gerard, Camille; Zimmer, Lisa; Lo, Serigne; Michielin, Olivier; Lebbe, Celeste; Mangana, Johanna; Ascierto, Paolo Antonio; Johnson, Douglas B.; Carlino, Matteo; Menzies, Alexander; Long, Georgina
    Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 7, e004610
    DOI (Open Access)
  • Bhave, Prachi; Ahmed, Tasnia; Lo, Serigne N.; Shoushtari, Alexander; Zaremba-Montenari, Anne; Versluis, Judith M.; Mangana, Joanna; Weichenthal, Michael; Si, Lu; Lesimple, Thierry; Robert, Caroline; Trojanello, Claudia; Wicky, Alexandre; Heywood, Richard; Tran, Lena; Batty, Kathleen; Dimitriou, Florentia; Stansfeld, Anna; Allayous, Clara; Schwarze, Julia K.; Mooradian, Meghan J.; Klein, Oliver; Mehmi, Inderjit; Roberts-Thomson, Rachel; Maurichi, Andrea; Yeoh, Hui-Ling; Khattak, Adnan; Zimmer, Lisa; Blank, Christian U.; Ramelyte, Egle; Kähler, Katharina C.; Roy, Severine; Ascierto, Paolo A.; Michielin, Olivier; Lorigan, Paul C.; Johnson, Douglas B.; Plummer, Ruth; Lebbe, Celeste; Neyns, Bart; Sullivan, Ryan; Hamid, Omid; Santinami, Mario; McArthur, Grant A.; Haydon, Andrew M.; Long, Georgina V.; Menzies, Alexander M.; Carlino, Matteo S.
    Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 7
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Matull, Johanna; Roth, Sebastian; Placke, Jan-Malte; Chorti, Eleftheria; Zaremba, Anne; Lodde, Georg; Jansen, Philipp; Krefting, Frederik; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Ugurel, Selma; Schadendorf, Dirk; Hadaschik, Eva; Griewank, Klaus
    Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
    In: Cancers , Jg. 14 2022, Nr. 9, 2090
    DOI, Online Volltext (Open Access)
  • Zaremba, Anne; Jansen, Philipp; Murali, Rajmohan; Mayakonda, Anand; Riedel, Anna; Krahl, Dieter; Burkhardt, Hans; John, Stefan; Géraud, Cyrill; Philip, Manuel; Kretz, Julia; Möller, Inga; Stadtler, Nadine; Sucker, Antje; Paschen, Annette; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Susanne; Plass, Christoph; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, Pavlo; Griewank, Klaus
    Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
    In: Cancers , Jg. 14 2022, Nr. 17, 4066
    DOI, Online Volltext (Open Access)
  • Zaremba-Montenari, Anne; Jansen, Philipp; Murali, Rajmohan; Mayakonda, Anand; Riedel, Anna; Philip, Manuel; Rose, Christian; Schaller, Jörg; Müller, Hansgeorg; Kutzner, Heinz; Möller, Inga; Stadtler, Nadine; Kretz, Julia; Sucker, Antje; Bankfalvi, Agnes; Livingstone, Elisabeth; Zimmer, Lisa; Horn, Susanne; Paschen, Annette; Plass, Christoph; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, Pavlo; Griewank, Klaus
    Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors
    In: International Journal of Cancer , Jg. 151 2022, Nr. 9, S. 1542 – 1554
    DOI (Open Access)
  • Lodde, Georg; Jansen, Philipp; Möller, Inga; Sucker, Antje; Hassel, Jessica C.; Forschner, Andrea; Eckardt, Julia; Meier, Friedegund; Reinhardt, Lydia; Kähler, Katharina C.; Ziemer, Mirjana; Schlaak, Max; Rahimi, Farnaz; Schatton, Kerstin; Meiss, Frank; Gutzmer, Ralf; Pföhler, Claudia; Terheyden, Patrick; Schilling, Bastian; Sachse, Michael; Heppt, Markus V.; Sindrilaru, Anca; Leiter, Ulrike; Zaremba, Anne; Thielmann, Carl Maximilian; Ugurel, Selma; Zimmer, Lisa; Hadaschik, Eva; Bechrakis, Nikolaos E.; Schadendorf, Dirk; Westekemper, Henrike; Livingstone, Elisabeth; Griewank, Klaus G.; German Dermatologic Cooperative Oncology Group (DeCOG, committee ocular melanoma)
    Genetic characterization of advanced conjunctival melanoma and response to systemic treatment
    In: European Journal of Cancer (EJC) , Jg. 166 2022, S. 60 – 72
    DOI
  • Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebastian; Kaatz, Martin; Forschner, Andrea; Leiter, Ulrike; Nashan, Dorothee; Kreuter, Alexander; Sachse, Michael; Welzel, Julia; Heinzerling, Lucie; Meiss, Frank; Weishaupt, Carsten; Gambichler, Thilo; Weyandt, Gerhard; Dippel, Edgar; Schatton, Kerstin; Celik, Eren; Trommer, Maike; Helfrich, Iris; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, Susanne; Ugurel, Selma
    Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis : a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 6, e004509
    DOI (Open Access)
  • Glutsch, Valerie; Schummer, Patrick; Kneitz, Hermann; Gesierich, Anja; Goebeler, Matthias; Klein, Detlef; Posch, Christian; Gebhardt, Christoffer; Haferkamp, Sebastian; Zimmer, Lisa; Becker, Jürgen; Leiter, Ulrike; Weichenthal, Michael; Schadendorf, Dirk; Ugurel, Selma; Schilling, Bastian
    Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma : A multicenter study of the prospective skin cancer registry ADOREG
    In: Journal for ImmunoTherapy of Cancer , Jg. 10 2022, Nr. 11, e005930
    DOI (Open Access)
  • Jansen, Philipp; Lodde, Georg; Griewank, Klaus; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk
    Management of partial and non-responding cutaneous squamous cell carcinoma
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 36 2022, Nr. S1, S. 29 – 34
    DOI (Open Access)
  • Ferdinandus, Justin; Zaremba-Montenari, Anne; Zimmer, Lisa; Umutlu, Lale; Seifert, Robert; Barbato, Francesco; Ugurel, Selma; Chorti, Eleftheria; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth
    Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
    In: Cancer Imaging , Jg. 22 2022, Nr. 1
    DOI, Online Volltext (Open Access)
  • Schuler, Martin; Zimmer, Lisa; Kim, Kevin B.; Sosman, Jeffrey A.; Ascierto, Paolo A.; Postow, Michael A.; De Vos, Filip Y.F.L.; van Herpen, Carla M.L.; Carlino, Matteo S.; Johnson, Douglas B.; Berking, Carola; Reddy, Micaela B.; Harney, Allison S.; Berlin, Jordan D.; Amaria, Rodabe N.
    Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma
    In: Clinical Cancer Research , Jg. 28 2022, Nr. 14, S. 3002 – 3010
    DOI (Open Access)
  • Garbe, Claus; Keim, Ulrike; Amaral, Teresa; Berking, Carola; Eigentler, Thomas K.; Flatz, Lukas; Gesierich, Anja; Leiter, Ulrike; Stadler, Rudolf; Sunderkötter, Cord; Tüting, Thomas; Utikal, Jochen; Wollina, Uwe; Zimmer, Lisa; Zouboulis, Christos C.; Ascierto, Paolo A.; Eggermont, Alexander M.M.; Grob, Jean-Jacques; Hauschild, Axel; Sekulovic, Lidija Kandolf; Long, Georgina V.; Luke, Jason J.; Michielin, Olivier; Peris, Ketty; Schadendorf, Dirk; Kirkwood, John M.; Lorigan, Paul C.
    Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts : Implications for Adjuvant Treatment
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 32, S. 3741 – 3749
    DOI (Open Access)
  • Ferdinandus, Justin; Fendler, Wolfgang; Lückerath, Katharina; Berliner, Christoph; Kurzidem, Sabine; Hadaschik, Eva; Klode, Joachim; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Herrmann, Ken; Becker, Jürgen; Ugurel, Selma
    Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
    In: Journal of Nuclear Medicine (JNM) , Jg. 63 2022, Nr. 3, S. 396 – 398
    DOI (Open Access)
  • Pohl, Julia; Totzeck, Matthias; Mincu, Raluca‐I.; Margraf, Simone M.; Scheipers, Lena; Michel, Lars; Mahabadi, Amir Abbas; Zimmer, Lisa; Rassaf, Tienush; Hendgen-Cotta, Ulrike B.
    Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy
    In: ESC Heart Failure , Jg. 9 2022, Nr. 5, S. 3533 – 3542
    DOI, Online Volltext (Open Access)
  • Dimitriou, F.; Namikawa, K.; Reijers, I.L.M.; Buchbinder, E.I.; Soon, J.A.; Zaremba-Montenari, Anne; Teterycz, P.; Mooradian, M.J.; Armstrong, E.; Nakamura, Y.; Vitale, M.G.; Tran, L.E.; Bai, X.; Allayous, C.; Provent-Roy, S.; Indini, A.; Bhave, P.; Farid, M.; Kähler, K.C.; Mehmi, I.; Atkinson, V.; Klein, O.; Stonesifer, C.J.; Zaman, F.; Haydon, A.; Carvajal, R.D.; Hamid, O.; Dummer, R.; Hauschild, A.; Carlino, M.S.; Mandala, M.; Robert, C.; Lebbe, C.; Guo, J.; Johnson, D.B.; Ascierto, P.A.; Shoushtari, A.N.; Sullivan, R.J.; Cybulska-Stopa, B.; Rutkowski, P.; Zimmer, L.; Sandhu, S.; Blank, C.U.; Lo, S.N.; Menzies, A.M.; Long, G.V.
    Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma : An international, retrospective, cohort study
    In: Annals of Oncology , Jg. 33 2022, Nr. 9, S. 968 – 980
    DOI
  • Thielmann, Carl Maximilian; Matull, Johanna; Zaremba, Anne; Murali, Rajmohan; Chorti, Eleftheria; Lodde, Georg; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus G.
    TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
    In: European Journal of Cancer (EJC) , Jg. 161 2022, S. 99 – 107
    DOI (Open Access)
  • Michel, Lars; Helfrich, Iris; Hendgen-Cotta, Ulrike Barbara; Mincu, Raluca-Ileana; Korste, Sebastian; Mrotzek, Simone Maria; Spomer, Armin; Odersky, Andrea; Rischpler, Christoph; Herrmann, Ken; Umutlu, Lale; Coman, Cristina; Ahrends, Robert; Sickmann, Albert; Löffek, Stefanie; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Gunzer, Matthias; Schadendorf, Dirk; Totzeck, Matthias; Rassaf, Tienush
    Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
    In: European Heart Journal , Jg. 43 2022, Nr. 4, S. 316 – 329
    DOI
  • Hegedüs, Luca; Livingstone, Elisabeth; Bankfalvi, Agnes; Viehof, Jan; Enyedi, Ágnes; Bilecz, Ágnes; Győrffy, Balázs; Baranyi, Marcell; Tőkés, Anna-Mária; Gil, Jeovanis; Marko-Varga, György; Griewank, Klaus; Zimmer, Lisa; Váraljai, Renáta; Sucker, Antje; Zaremba, Anne; Schadendorf, Dirk; Aigner, Clemens; Hegedüs, Balázs
    The Prognostic Relevance of PMCA4 Expression in Melanoma : Gender Specificity and Implications for Immune Checkpoint Inhibition
    In: International Journal of Molecular Sciences (IJMS) , Jg. 23 2022, Nr. 6, 3324
    DOI, Online Volltext (Open Access)
  • Placke, Jan-Malte; Rawitzer, Josefine; Reis, Henning; Rashidi-Alavijeh, Jassin; Livingstone, Elisabeth; Ugurel, Selma; Hadaschik, Eva; Griewank, Klaus; Schmid, Kurt Werner; Schadendorf, Dirk; Rösch, Alexander; Zimmer, Lisa
    Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition : Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 Immunohistochemistry
    In: Frontiers in Oncology , Jg. 11 2021, 725549
    DOI, Online Volltext (Open Access)
  • Schmidt, Teresa; Kebir, Sied; Livingstone, Elisabeth; Junker, Andreas; Zülow, Stefan; Lazaridis, Lazaros; Oster, Christoph; Chorti, Eleftheria; Pierscianek, Daniela; Pul, Refik; Keyvani, Kathy; Sure, Ulrich; Stuschke, Martin; Kleinschnitz, Christoph; Scheffler, Björn; Zimmer, Lisa; Glas, Martin
    Case Report : Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma
    In: Frontiers in Oncology , Jg. 11 2021, S. 637185
    DOI, Online Volltext (Open Access)
  • Zaremba, Anne; Philip, Manuel; Hassel, Jessica C.; Glutsch, Valerie; Fiocco, Zeno; Loquai, Carmen; Rafei-Shamsabadi, David; Gutzmer, Ralf; Utikal, Jochen; Haferkamp, Sebastian; Reinhardt, Lydia; Kähler, Katharina C.; Weishaupt, Carsten; Moreira, Alvaro; Thoms, Kai-Martin; Wilhelm, Tabea; Pföhler, Claudia; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Stadtler, Nadine; Sucker, Antje; Kiecker, Felix; Heinzerling, Lucie; Meier, Friedegund; Meiss, Frank; Schlaak, Max; Schilling, Bastian; Horn, Susanne; Schadendorf, Dirk; Livingstone, Elisabeth
    Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
    In: European Journal of Cancer (EJC) , Jg. 152 2021, S. 139 – 154
    DOI
  • Rogiers, Aljosja; Da Silva, Ines Pires; Tentori, Chiara; Tondini, Carlo Alberto; Grimes, Joseph M.; Trager, Megan H.; Nahm, Sharon; Zubiri, Leyre; Manos, Michael; Bowling, Peter; Elkrief, Arielle; Papneja, Neha; Vitale, Maria Grazia; Rose, April A.N.; Borgers, Jessica S.W.; Roy, Severine; Mangana, Joanna; Pimentel Muniz, Thiago; Cooksley, Tim; Lupu, Jeremy; Vaisman, Alon; Saibil, Samuel D.; Butler, Marcus O.; Menzies, Alexander M.; Carlino, Matteo S.; Erdmann, Michael; Berking, Carola; Zimmer, Lisa; Schadendorf, Dirk; Pala, Laura; Queirolo, Paola; Posch, Christian; Hauschild, Axel; Dummer, Reinhard; Haanen, John; Blank, Christian U.; Robert, Caroline; Sullivan, Ryan J.; Ascierto, Paolo Antonio; Miller, Wilson H; Stephen Hodi, F.; Suijkerbuijk, Karijn P.M.; Reynolds, Kerry L.; Rahma, Osama E.; Lorigan, Paul C.; Carvajal, Richard D.; Lo, Serigne; Mandala, Mario; Long, Georgina V.
    Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
    In: Journal for ImmunoTherapy of Cancer , Jg. 9 2021, Nr. 1, e001931
    DOI (Open Access)
  • Franklin, Cindy; Wetter, Axel; Baba, Hideo Andreas; Theysohn, Jens; Haubold, Johannes; Cosgarea, Ioana; Hadaschik, Eva; Livingstone, Elisabeth; Zimmer, Lisa; Stoffels, Ingo; Klode, Joachim; Lodde, Georg; Placke, Jan-Malte; Schadendorf, Dirk; Ugurel, Selma
    Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer : A retrospective analysis of 47 cases
    In: European Journal of Cancer (EJC) , Jg. 150 2021, S. 119 – 129
    DOI
  • Owen, Carina N.; Bai, Xiumei; Quah, T.; Lo, Serigne N.; Allayous, Clara; Callaghan, S.; Martínez-Vila, Clara; Wallace, Roslyn; Bhave, Prachi; Reijers, Irene L.M.; Thompson, Nicola; Vanella, Vito; Gérard, Camille L.; Aspeslagh, Sandrine; Labianca, Alice; Khattak, Muhammad Adnan; Mandala, Mario; Xu, Wen; Neyns, Bart; Michielin, Olivier; Blank, Christian U.; Welsh, Sarah J.; Haydon, Andrew M.; Sandhu, Shahneen K.; Mangana, Joanna; McQuade, Jennifer Leigh; Ascierto, Paolo A.; Zimmer, Lisa; Johnson, Douglas B.; Arance, Ana María; Lorigan, Paul C.; Lebbé, Célèste; Carlino, Matteo S.; Sullivan, Ryan Joseph; Long, Georgina V.; Menzies, Alexander M.
    Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
    In: Annals of Oncology , Jg. 32 2021, Nr. 7, S. 917 – 925
    DOI (Open Access)
  • Bolz, Saskia; Ramakrishnan, Thivyah; Fleischer, Michael; Livingstone, Elisabeth; Stolte, Benjamin; Thimm, Andreas; Kizina, Kathrin; Ugurel, Selma; Kleinschnitz, Christoph; Glas, Martin; Zimmer, Lisa; Hagenacker, Tim
    Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy
    In: eNeurologicalSci , Jg. 22 2021, 100324
    DOI (Open Access)
  • Placke, Jan-Malte; Soun, Camille; Bottek, Jenny; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Pfeiffer, Christiane; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, Antje; Griewank, Klaus; Horn, Susanne; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Engel, Daniel Robert; Ugurel, Selma
    Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic Melanoma
    In: Frontiers in Oncology , Jg. 11 2021, 741993
    DOI, Online Volltext (Open Access)
  • Stege, Henner; Haist, Maximilian; Schultheis, Michael; Fleischer, Maria Isabel; Mohr, Peter; Meier, Friedegund; Schadendorf, Dirk; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa; Herbst, Rudolf; Pföhler, Claudia; Kähler, Katharina; Weichenthal, Michael; Terheyden, Patrick; Nashan, Dorothée; Debus, Dirk; Kaatz, Martin; Ziller, Fabian; Haferkamp, Sebastian; Forschner, Andrea; Leiter, Ulrike; Kreuter, Alexander; Ulrich, Jens; Kleemann, Johannes; Bradfisch, Fabienne; Grabbe, Stephan; Loquai, Carmen
    Discontinuation of braf/mek-directed targeted therapy after complete remission of metastatic melanoma : a retrospective multicenter adoreg study
    In: Cancers , Jg. 13 2021, Nr. 10, S. 2312
    DOI (Open Access)
  • Kähler, Katharina C.; Gutzmer, Ralf; Meier, Friedegrund; Zimmer, Lisa; Heppt, Markus; Gesierich, Anja; Thoms, Kai-Martin; Utikal, Jochen; Hassel, Jessica C.; Loquai, Carmen; Pföhler, Claudia; Heinzerling, Lucie; Kaatz, Martin; Göppner, Daniela; Pflugfelder, Annette; Bohne, Ann-Sophie; Satzger, Imke; Reinhardt, Lydia; Placke, Jan-Malte; Schadendorf, Dirk; Ugurel, Selma
    Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma : A Retrospective Multicenter DeCOG Study
    In: Frontiers in Oncology , Jg. 11 2021, 672172
    DOI (Open Access)
  • Zimmer, Lisa; Livingstone, Elisabeth; Krackhardt, Angela; Schultz, Erwin S.; Göppner, Daniela; Assaf, Chalid; Trebing, Dietrich; Stelter, Kai; Windemuth-Kieselbach, Christine; Ugurel, Selma; Schadendorf, Dirk
    Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAFV⁶⁰⁰ mutant melanoma : safety and tolerability results from the phase I IMMU-TARGET trial
    In: European Journal of Cancer (EJC) , Jg. 158 2021, S. 72 – 84
    DOI
  • Lodde, Georg; Forschner, Andrea; Hassel, Jessica; Wulfken, Lena M.; Meier, Friedegund; Mohr, Peter; Kähler, Katharina; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Schatton, Kerstin; Gebhardt, Christoffer; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Stang, Andreas; Kowall, Bernd; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Factors influencing the adjuvant therapy decision : Results of a real-world multicenter data analysis of 904 melanoma patients
    In: Cancers , Jg. 13 2021, Nr. 10, S. 2319
    DOI, Online Volltext (Open Access)
  • Zaremba, Anne; Kramer, Rafaela; De Temple, Viola; Bertram, Stefanie; Salzmann, Martin; Gesierich, Anja; Reinhardt, Lydia; Baroudjian, Barouyr; Sachse, Michael M.; Mechtersheimer, Gunhild; Johnson, Douglas B.; Weppler, Alison M.; Spain, Lavinia; Loquai, Carmen; Dudda, Milena; Pföhler, Claudia; Hepner, Adriana; Long, Georgina V.; Menzies, Alexander M.; Carlino, Matteo S.; Lebbé, Céleste; Enokida, Tomohiro; Tahara, Makoto; Bröckelmann, Paul J.; Eigentler, Thomas; Kähler, Katharina C.; Gutzmer, Ralf; Berking, Carola; Ugurel, Selma; Stadtler, Nadine; Sucker, Antje; Becker, Jürgen; Livingstone, Elisabeth; Meier, Friedegund; Hassel, Jessica C.; Schadendorf, Dirk; Hanoun, Maher; Heinzerling, Lucie; Zimmer, Lisa
    Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition : A Descriptive Observational Retrospective Multicenter Analysis
    In: Frontiers in Oncology , Jg. 11 2021, 765608
    DOI, Online Volltext (Open Access)
  • Kramer, Rafaela; Zaremba, Anne; Moreira, Alvaro; Ugurel, Selma; Johnson, Douglas B.; Hassel, Jessica C.; Salzmann, Martin; Gesierich, Anja; Weppler, Alison; Spain, Lavinia; Loquai, Carmen; Dudda, Milena; Pföhler, Claudia; Hepner, Adriana; Long, Georgina V.; Menzies, Alexander M.; Carlino, Matteo S.; Sachse, Michael M.; Lebbé, Céleste; Baroudjian, Barouyr; Enokida, Tomohiro; Tahara, Makoto; Schlaak, Max; Hayani, Kinan; Bröckelmann, Paul J.; Meier, Friedegund; Reinhardt, Lydia; Friedlander, Philip; Eigentler, Thomas; Kähler, Katharina C.; Berking, Carola; Zimmer, Lisa; Heinzerling, Lucie
    Hematological immune related adverse events after treatment with immune checkpoint inhibitors
    In: European Journal of Cancer (EJC) , Jg. 147 2021, S. 170 – 181
    DOI
  • Dearden, Helen; Au, Lewis; Wang, Daniel Y.; Zimmer, Lisa; Eroglu, Zeynep; Smith, Jessica L.; Cuvietto, Marcello; Khoo, Chloe; Atkinson, Victoria; Lo, Serigne; Long, Georgina V.; Sandhu, Shahneen; Ascierto, Paolo A.; Carlino, Matteo S.; Johnson, Douglas B.; Larkin, James; Menzies, Alexander M.
    Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy
    In: European Journal of Cancer (EJC) , Jg. 153 2021, S. 168 – 178
    DOI
  • Pires da Silva, Ines; Ahmed, Tasnia; Reijers, Irene L. M.; Weppler, Alison M.; Betof Warner, Allison; Patrinely, James Randall; Serra-Bellver, Patricio; Allayous, Clara; Mangana, Joanna; Nguyen, Khang; Zimmer, Lisa; Trojaniello, Claudia; Stout, Dan; Lyle, Megan; Klein, Oliver; Gerard, Camille L.; Michielin, Olivier; Haydon, Andrew; Ascierto, Paolo A.; Carlino, Matteo S.; Lebbe, Celeste; Lorigan, Paul; Johnson, Douglas B.; Sandhu, Shahneen; Lo, Serigne N.; Blank, Christian U.; Menzies, Alexander M.; Long, Georgina V.
    Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy : A multicentre, retrospective, cohort study
    In: The Lancet Oncology , Jg. 22 2021, Nr. 6, S. 836 – 847
    DOI
  • Zimmer, Lisa
    Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma : Authors' reply
    In: The Lancet Oncology , Jg. 22 2021, Nr. 8, S. E343 – E344
    DOI
  • Albrecht, Margarete; Hadaschik, Eva; Zimmer, Lisa; Livingstone, Elisabeth; Hamacher, Rainer; Bauer, Sebastian; Schadendorf, Dirk; Ugurel, Selma
    Kutanes Angiosarkom mit klinischem Bild eines Quincke-Ödems
    In: Der Hautarzt , Jg. 72 2021, Nr. 9, S. 801 – 804
    DOI (Open Access)
  • Chorti, Eleftheria; Kebir, Sied; Ahmed, Misbah S.; Keyvani, Kathy; Umutlu, Lale; Kanaki, Theodora; Zaremba, Anne; Reinboldt-Jockenhöfer, Finja; Knispel, Sarah; Gratsias, Emmanouil; Rösch, Alexander; Ugurel, Selma; Scheffler, Björn; Schadendorf, Dirk; Livingstone, Elisabeth; Meier, Friedegund; Glas, Martin; Zimmer, Lisa
    Leptomeningeal disease from melanoma : Poor prognosis despite new therapeutic modalities
    In: European Journal of Cancer (EJC) , Jg. 148 2021, S. 395 – 404
    DOI
  • Grimmelmann, Imke; Momma, Michael; Zimmer, Lisa; Hassel, Jessica C.; Heinzerling, Lucie; Pföhler, Claudia; Loquai, Carmen; Ruini, Cristel; Utikal, Jochen; Thoms, Kai-Martin; Kähler, Katharina C.; Eigentler, Thomas; Herbst, Rudolf A.; Meier, Friedegund; Debus, Dirk; Berking, Carola; Kochanek, Corinna; Ugurel, Selma; Gutzmer, Ralf
    Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy : A multicentre study of 90 patients from the German Dermatooncology Group
    In: European Journal of Cancer (EJC) , Jg. 149 2021, S. 1 – 10
    DOI
  • Bhave, Prachi; Pallan, Lalit; Long, Georgina V.; Menzies, Alexander M.; Atkinson, Victoria; Cohen, Justine V.; Sullivan, Ryan J.; Chiarion-Sileni, Vanna; Nyakas, Marta; Kähler, Katharina; Hauschild, Axel; Plummer, Ruth; Trojaniello, Claudia; Ascierto, Paolo A.; Zimmer, Lisa; Schadendorf, Dirk; Allayous, Clara; Lebbe, Celeste; Maurichi, Andrea; Santinami, Mario; Roy, Severine; Robert, Caroline; Lesimple, Thierry; Patel, Sapna; Versluis, Judith M.; Blank, Christian U.; Khattak, Adnan; Van der Westhuizen, Andre; Carlino, Matteo S.; Shackleton, Mark; Haydon, Andrew
    Melanoma recurrence patterns and management after adjuvant targeted therapy : A multicentre analysis
    In: British Journal of Cancer (BJC) , Jg. 124 2021, Nr. 3, S. 574 – 580
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa; Paredes, Bruno E.; Brinkmeier, Thomas; Griewank, Klaus; Schadendorf, Dirk; Klode, Joachim; Stoffels, Ingo; Hadaschik, Eva
    Metastatic pigmented epithelioid melanocytoma in a 7-year-old female
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. 8, S. 1217 – 1219
    DOI (Open Access)
  • Zaremba, Anne; Lodde, Georg; Murali, Rajmohan; Philip, Manuel; Cosgarea, Ioana; Jansen, Philipp; Chorti, Eleftheria; Rose, Christian; Hemmerlein, Bernhard; Matull, Johanna; Thielmann, Carl Maximilian; Kretz, Julia; Möller, Inga; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Horn, Susanne; Schadendorf, Dirk; Hadaschik, Eva; Griewank, Klaus
    Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology
    In: European Journal of Cancer (EJC) , Jg. 148 2021, S. 340 – 347
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Chorti, Eleftheria; Matull, Johanna; Murali, Rajmohan; Zaremba-Montenari, Anne; Lodde, Georg; Jansen, Philipp; Richter, Luisa; Kretz, Julia; Möller, Inga; Sucker, Antje; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichenthal, Michael; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Hadaschik, Eva; Ugurel, Selma; Griewank, Klaus
    NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
    In: European Journal of Cancer (EJC) , Jg. 159 2021, S. 113 – 124
    DOI
  • Knispel, Sarah; Gassenmaier, Maximilian; Menzies, Alexander M.; Loquai, Carmen; Johnson, Douglas B.; Franklin, Cindy; Gutzmer, Ralf; Hassel, Jessica C.; Weishaupt, Carsten; Eigentler, Thomas; Schilling, Bastian; Schummer, Patrick; Sirokay, Judith; Kiecker, Felix; Owen, Carina N.; Fleischer, Maria I.; Cann, Christopher; Kähler, Katharina C.; Mohr, Peter; Bluhm, Leonie; Niebel, Dennis; Thoms, Kai-Martin; Goldinger, Simone M.; Reinhardt, Lydia; Meier, Friedegund; Berking, Carola; Reinhard, Raphael; Susok, Laura; Ascierto, Paolo A.; Drexler, Konstantin; Pföhler, Claudia; Tietze, Julia; Heinzerling, Lucie; Livingstone, Elisabeth; Ugurel, Selma; Long, Georgina V.; Stang, Andreas; Schadendorf, Dirk; Zimmer, Lisa
    Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition
    In: European Journal of Cancer (EJC) , Jg. 148 2021, S. 61 – 75
    DOI
  • Steeb, Theresa; Wessely, Anja; Alter, Mareike; Bayerl, Christiane; Bender, Armin; Bruning, Guido; Dabrowski, Evelyn; Debus, Dirk; Devereux, Nina; Dippel, Edgar; Drexler, Konstantin; Dücker, Pia; Dummer, Reinhard; Emmert, Steffen; Elsner, Peter; Enk, Alexander; Gebhardt, Christoffer; Gesierich, Anja; Goebeler, Matthias; Goerdt, Sergij; Goetze, Steven; Gutzmer, Ralf; Haferkamp, Sebastian; Hansel, Gesina; Hassel, Jessica C.; Heinzerling, Lucie; Kähler, Katharina C.; Kaume, Kjell M.; Krapf, Wolfgang; Kreuzberg, Nicole; Lehmann, Percy; Livingstone, Elisabeth; Löffler, Harald; Loquai, Carmen; Mauch, Cornelia; Mangana, Johanna; Meier, Friedegund; Meissner, Markus; Moritz, Rose K. C.; Maul, Lara Valeska; Müller, Verena; Mohr, Peter; Navarini, Alexander; Van Nguyen, Ahn; Pfeiffer, Christiane; Pföhler, Claudia; Posch, Christian; Richtig, Erika; Rompel, Rainer; Sachse, Michael M.; Sauder, Stefanie; Schadendorf, Dirk; Schatton, Kerstin; Schulze, Hans-Joachim; Schultz, Erwin; Schilling, Bastian; Schmuth, Matthias; Simon, Jan. C.; Streit, Markus; Terheyden, Patrick; Thiem, Alexander; Tüting, Thomas; Welzel, Julia; Weyandt, Gerhard; Wesselmann, Ulrich; Wollina, Uwe; Ziemer, Mirjana; Zimmer, Lisa; Zutt, Markus; Berking, Carola; Schlaak, Max; Heppt, Markus V.
    Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries : A multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)
    In: Journal of Cancer Research and Clinical Oncology , Jg. 147 2021, Nr. 6, S. 1763 – 1771
    DOI (Open Access)
  • Hepner, Adriana; Atkinson, Victoria G.; Larkin, James; Burrell, Rebecca A.; Carlino, Matteo S.; Johnson, Douglas B.; Zimmer, Lisa; Tsai, Katy K.; Klein, Oliver; Lo, Serigne N.; Haydon, Andrew; Bhave, Prachi; Lyle, Megan; Pallan, Lalit; Pires da Silva, Ines; Gerard, Camille; Michielin, Olivier; Long, Georgina V.; Menzies, Alexander M.
    Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti–PD-1 therapy
    In: European Journal of Cancer (EJC) , Jg. 153 2021, S. 213 – 222
    DOI
  • Hilbers, Marie-Luise; Dimitriou, Florentia; Lau, Peter; Bhave, Prachi; McArthur, Grant A.; Zimmer, Lisa; Kudura, Ken; Gérard, Camille L.; Levesque, Mitchell P.; Michielin, Olivier; Dummer, Reinhard; Cheng, Phil F.; Mangana, Joanna
    Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases
    In: European Journal of Cancer (EJC) , Jg. 156 2021, S. 149 – 163
    DOI (Open Access)
  • Brase, Jan C.; Walter, Robert F.H.; Savchenko, Alexander; Gusenleitner, Daniel; Garrett, James; Schimming, Tobias; Varaljai, Renata; Castelletti, Deborah; Kim, Ju; Dakappagari, Naveen; Schultz, Ken; Robert, Caroline; Long, Georgina V.; Nathan, Paul D.; Ribas, Antoni; Flaherty, Keith T.; Karaszewska, Boguslawa; Schachter, Jacob; Sucker, Antje; Schmid, Kurt Werner; Zimmer, Lisa; Livingstone, Elisabeth; Gasal, Eduard; Schadendorf, Dirk; Rösch, Alexander
    Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
    In: Clinical Cancer Research , Jg. 27 2021, Nr. 16, S. 4500 – 4510
    DOI (Open Access)
  • Moritz, Rose K.C.; Gutzmer, Ralf; Zimmer, Lisa; Meier, Friedegund; Ahmed, Misbah S.; Sell, Sabine; Schlaak, Max; Kapp, Florian; Sachse, Michael M.; Haferkamp, Sebastian; Welzel, Julia; Kähler, Katharina C.; Weichenthal, Michael
    SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry
    In: European Journal of Cancer (EJC) , Jg. 144 2021, S. 382 – 385
    DOI
  • Wessely, Anja; Steeb, Theresa; Berking, Carola; Schlaak, Max; Heppt, Markus V.; Alter, Mareike; Bayerl, Christiane; Bender, Armin; Bruning, Guido; Dabrowski, Evelyn; Debus, Dirk; Devereux, Nina; Dippel, Edgar; Drexler, Konstantin; Dücker, Pia; Dummer, Reinhard; Emmert, Steffen; Elsner, Peter; Enk, Alexander; Gebhardt, Christoffer; Gesierich, Anja; Goebeler, Matthias; Goerdt, Sergij; Goetze, Steven; Gutzmer, Ralf; Haferkamp, Sebastian; Hansel, Gesina; Hassel, Jessica C.; Heinzerling, Lucie; Kähler, Katharina C.; Kaume, Kjell M.; Krapf, Wolfgang; Kreuzberg, Nicole; Lehmann, Percy; Livingstone, Elisabeth; Löffler, Harald; Loquai, Carmen; Mauch, Cornelia; Mangana, Johanna; Meier, Friedegund; Meissner, Markus; Moritz, Rose K.C.; Maul, Lara Valeska; Müller, Verena; Mohr, Peter; Navarini, Alexander; Van Nguyen, Ahn; Pfeiffer, Christiane; Pföhler, Claudia; Posch, Christian; Richtig, Erika; Rompel, Rainer; Sachse, Michael M.; Sauder, Stefanie; Schadendorf, Dirk; Schatton, Kerstin; Schulze, Hans-Joachim; Schultz, Erwin; Schilling, Bastian; Schmuth, Matthias; Simon, Jan C.; Streit, Markus; Terheyden, Patrick; Thiem, Alexander; Tüting, Thomas; Welzel, Julia; Weyandt, Gerhard; Wesselmann, Ulrich; Wollina, Uwe; Ziemer, Mirjana; Zimmer, Lisa; Zutt, Markus
    Surveillance of patients with conjunctival melanoma in German-speaking countries : A multinational survey of the German dermatologic cooperative oncology group
    In: European Journal of Cancer (EJC) , Jg. 143 2021, S. 43 – 45
    DOI
  • Zaremba, Anne; Eggermont, Alexander M.M.; Robert, Caroline; Dummer, Reinhardt; Ugurel, Selma; Livingstone, Elisabeth; Ascierto, Paolo A.; Long, Georgina V.; Schadendorf, Dirk; Zimmer, Lisa
    The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients
    In: European Journal of Cancer (EJC) , Jg. 155 2021, S. 268 – 280
    DOI
  • Versluis, Judith M.; Hendriks, Anne M.; Weppler, Alison M.; Brown, Lauren J.; de Joode, Karlijn; Suijkerbuijk, Karijn P.M.; Zimmer, Lisa; Kapiteijn, Ellen W.; Allayous, Clara; Johnson, Douglas B.; Hepner, Adriana; Mangana, Joanna; Bhave, Prachi; Jansen, Yanina J.L.; Trojaniello, Claudia; Atkinson, Victoria; Storey, Lucy; Lorigan, Paul; Ascierto, Paolo A.; Neyns, Bart; Haydon, Andrew; Menzies, Alexander M.; Long, Georgina V.; Lebbe, Celeste; van der Veldt, Astrid A.M.; Carlino, Matteo S.; Sandhu, Shahneen; van Tinteren, Harm; de Vries, Elisabeth G.E.; Blank, Christian U.; Jalving, Mathilde
    The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition : A multicentre retrospective analysis
    In: European Journal of Cancer (EJC) , Jg. 151 2021, S. 72 – 83
    DOI (Open Access)
  • Zimmer, Lisa; Livingstone, Elisabeth; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kieker, Felix; Dippel, Edgar; Rösch, Alexander; Simon, Jan-Christoph; Conrad, Beate; Körner, Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus; Becker, Jürgen C.; Schadendorf, Dirk; Berking, Carola; Herbst, Rudolf A.; Martens, Uwe M; Sell, Sabine; Stadler, Rudolf; Terheyden, Patrick; Utikal, Jochen
    Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : A randomised, double-blind, placebo-controlled, phase 2 trial
    In: Lancet , Jg. 395 2020, Nr. 10236, S. 1558 – 1568
    DOI
  • Liu, David; Schilling, Bastian; Liu, Derek; Sucker, Antje; Livingstone, Elisabeth; Jerby-Arnon, Livnat; Zimmer, Lisa; Gutzmer, Ralf; Satzger, Imke; Loquai, Carmen; Grabbe, Stephan; Vokes, Natalie; Margolis, Claire A.; Conway, Jake; He, Meng Xiao; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Tracy, Adam; Gogas, Helen; Goldinger, Simone M.; Utikal, Jochen; Blank, Christian U.; Rauschenberg, Ricarda; von Bubnoff, Dagmar; Krackhardt, Angela; Weide, Benjamin; Haferkamp, Sebastian; Kiecker, Felix; Izar, Ben; Garraway, Levi; Regev, Aviv; Flaherty, Keith; Paschen, Annette; Van Allen, Eliezer M.; Schadendorf, Dirk
    Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
    In: Nature Medicine , Jg. 26 2020, Nr. 7, S. 1147
    DOI (Open Access)
  • David, Paul; Drabczyk-Pluta, Malgorzata; Pastille, Eva; Knuschke, Torben; Werner, Tanja; Honke, Nadine; Megger, Dominik A.; Akhmetzyanova, Ilseyar; Shaabani, Namir; Eyking-Singer, Annette; Cario, Elke; Kershaw, Olivia; Gruber, Achim D.; Tenbusch, Matthias; Dietze, Kirsten; Trilling, Mirko; Liu, Jia; Schadendorf, Dirk; Streeck, Hendrik; Lang, Karl S.; Xie, Youhua; Zimmer, Lisa; Sitek, Barbara; Paschen, Annette; Westendorf, Astrid; Dittmer, Ulf; Zelinskyy, Gennadiy
    Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology
    In: PLoS Pathogens , Jg. 16 2020, Nr. 3, e1008340
    DOI (Open Access)
  • Amaral, Teresa; Kiecker, Felix; Schaefer, Sarah; Stege, Henner; Kaehler, Katharina; Terheyden, Patrick; Gesierich, Anja; Gutzmer, Ralf; Haferkamp, Sebastian; Uttikal, Jochen; Berking, Carola; Rafei-Shamsabadi, David; Reinhardt, Lydia; Meier, Friedegund; Karoglan, Ante; Posch, Christian; Gambichler, Thilo; Pfoehler, Claudia; Thoms, Kai; Tietze, Julia; Debus, Dirk; Herbst, Rudolf; Emmert, Steffen; Loquai, Carmen; Hassel, Jessica C; Meiss, Frank; Tueting, Thomas; Heinrich, Vanessa; Eigentler, Thomas; Garbe, Claus; Zimmer, Lisa
    Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis : A DeCOG∗ study in 380 patients
    In: Journal for ImmunoTherapy of Cancer , Jg. 8 2020, Nr. 1
    DOI (Open Access)
  • Chorti, Eleftheria; Kanaki, Theodora; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Gratsias, Emmanouil; Rösch, Alexander; Bonella, Francesco; Wessendorf, Thomas; Wälscher, Julia; Theegarten, Dirk; Schadendorf, Dirk; Livingstone, Elisabeth
    Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy : Increased rate and mimicker of metastasis
    In: European Journal of Cancer (EJC) , Jg. 131 2020, S. 18 – 26
    DOI
  • Matull, Johanna; Livingstone, Elisabeth; Wetter, Axel; Zimmer, Lisa; Zaremba, Anne; Lahner, Harald; Schadendorf, Dirk; Ugurel, Selma
    Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade : A Case Report
    In: Frontiers in Oncology , Jg. 10 2020, S. 592609
    DOI, Online Volltext (Open Access)
  • Pohl, Julia; Mincu, Raluca-Ileana; Mrotzek, Simone Maria; Hinrichs, Lena; Michel, Lars; Livingstone, Elisabeth; Zimmer, Lisa; Wakili, Reza; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias
    ECG Changes in Melanoma Patients Undergoing Cancer Therapy : Data from the ECoR Registry
    In: Journal of Clinical Medicine (JCM) , Jg. 9 2020, Nr. 7, 2060
    DOI, Online Volltext (Open Access)
  • Ugurel, Selma; Schadendorf, Dirk; Horny, K.; Sucker, Antje; Schramm, Sabine; Utikal, Jochen; Pföhler, Claudia; Herbst, Rudolf A.; Schilling, B.; Blank, Christian U.; Becker, Jürgen; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Peter; Rebmann, Vera
    Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma
    In: Annals of Oncology , Jg. 31 2020, Nr. 1, S. 144 – 152
    DOI (Open Access)
  • Zaremba, Anne; Zimmer, Lisa; Chorti, Eleftheria; Reissig, Timm M.; Bauer, Sebastian; Podleska, Lars; Schulz, Andrea; Hadaschik, Eva; Griewank, Klaus; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Fatal swelling of the groin – Clear cell sarcoma : A rare but important differential diagnosis to malignant melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. 10, S. 1165 – 1168
    DOI (Open Access)
  • Livingstone, Elisabeth; Zaremba, Anne; Horn, Susanne; Ugurel, Selma; Casalini, Belén; Schlaak, Max; Hassel, Jessica Cecile; Herbst, Rudolf A.; Utikal, Jochen; Weide, Benjamin M.; Gutzmer, Ralf; Meier, Friedegund E.; Koelsche, Christian; Hadaschik, Eva; Sucker, Antje; Reis, Henning; Merkelbach-Bruse, Sabine; Siewert, Martina M.; Sahm, Felix; von Deimling, Andreas; Cosgarea, Ioana; Zimmer, Lisa; Schadendorf, Dirk; Schilling, Bastian; Griewank, Klaus
    GNAQ and GNA11 mutant nonuveal melanoma : A subtype distinct from both cutaneous and uveal melanoma
    In: British Journal of Dermatology: BJD , Jg. 183 2020, Nr. 5, S. 928 – 939
    DOI (Open Access)
  • Leiter, Ulrike; Loquai, Carmen; Reinhardt, Lydia; Rafei-Shamsabadi, David; Gutzmer, Ralf; Kaehler, Katharina; Heinzerling, Lucie; Hassel, Jessica C.; Glutsch, Valerie; Sirokay, Judith; Schlecht, Nora; Rübben, Albert; Gambichler, Thilo; Schatton, Kerstin; Pfoehler, Claudia; Franklin, Cindy; Terheyden, Patrick; Haferkamp, Sebastian; Mohr, Peter; Bischof, Lena; Livingstone, Elisabeth; Zimmer, Lisa; Weichenthal, Michael; Schadendorf, Dirk; Meiwes, Andreas; Keim, Ulrike; Garbe, Claus; Becker, Jürgen; Ugurel, Selma
    Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy : A retrospective multicenter DeCOG study of 84 patients
    In: Journal for ImmunoTherapy of Cancer , Jg. 8 2020, Nr. 2, S. e000897
    DOI (Open Access)
  • Zaremba, Anne; Zimmer, Lisa; Griewank, Klaus; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Immuntherapie beim malignen Melanom
    In: Der Internist , Jg. 61 2020, Nr. 7, S. 669 – 675
    DOI (Open Access)
  • Knispel, Sarah; Stang, Andreas; Zimmer, Lisa; Lax, Hildegard; Gutzmer, Ralf; Heinzerling, Lucie; Weishaupt, Carsten; Pföhler, Claudia; Gesierich, Anja; Herbst, Rudolf; Kaehler, Katharina C.; Weide, Benjamin; Berking, Carola; Loquai, Carmen; Utikal, Jochen; Terheyden, Patrick; Kaatz, Martin; Schlaak, Max; Kreuter, Alexander; Ulrich, Jens; Mohr, Peter; Dippel, Edgar; Livingstone, Elisabeth; Becker, Jürgen; Weichenthal, Michael; Chorti, Eleftheria; Gronewold, Janine; Schadendorf, Dirk; Ugurel, Selma
    Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma : A multicenter retrospective cohort study of the DeCOG
    In: Journal for ImmunoTherapy of Cancer , Jg. 8 2020, Nr. 1, S. e000395
    DOI (Open Access)
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Hautarzt , Jg. 71 2020, S. 63 – 77
    DOI
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Pathologe , Jg. 41 2020, Nr. 3, S. 281 – 292
    DOI
  • Zaremba, Anne; Zimmer, Lisa; Griewank, Klaus; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth
    Malignes Melanom : Stellenwert der BRAF-Inhibition beim malignen Melanom
    In: Der Onkologe , Jg. 26 2020, Nr. 8, S. 713 – 720
    DOI
  • Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Malignes Melanom
    In: Der Onkologe , Jg. 26 2020, Nr. 1, S. 75 – 87
    DOI
  • Kähler, Katharina C.; Hassel, Jessica C.; Heinzerling, Lucie; Loquai, Carmen; Thoms, Kai-Martin; Ugurel, Selma; Zimmer, Lisa; Gutzmer, Ralf
    Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD-1-Antikörper beim metastasierten Melanom : ein Update
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. 6, S. 582 – 609
    DOI (Open Access)
  • Salzmann, Martin; Leiter, Ulrike; Loquai, Carmen; Zimmer, Lisa; Ugurel, Selma; Gutzmer, Ralf; Thoms, Kai-Martin; Enk, Alexander H.; Hassel, Jessica C.
    Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma : real-world data of a retrospective, multicenter study
    In: European Journal of Cancer (EJC) , Jg. 138 2020, S. 125 – 132
    DOI
  • Eigentler, Thomas K.; Augustin, Matthias; Beer, Ambros J.; Bendel, Martin; Berking, Carola; Bölükbas, Servet; Dippel, Egdar; Fehm, Tanja; Feyer, Petra; Foilman, Markus; Forschner, Andrea; Frerich, Bernhard; Gärtner, Jan; Gutzmer, Ralf; Haferkamp, Sebastian; Hassel, Jessica C.; Hauschild, Axel; Heinzerling, Lucie; Heppt, Markus; Hübner, Jutta; Kähler, Katharina; Kiehl, Martina; Kölbl, Oliver; Krause-Bergmann, Albrecht; Lang, Stephan; Langer, Thomas; Leiter, Ulrike; Loquai, Carmen; Löser, Christoph; Mehlhorn, Grit; Meier, Friedegund; Meissner, Markus; Mohr, Peter; Müller, Cornelia; Nehls, Wiebke; Noah, Ernst Magnus; Rösch, Alexander; Schilling, Bastian; Schmid-Wendtner, Monika; Tietze, Julia; Vogt, Thomas; Wehrmann, Jochen; Weichenthal, Michael; Weide, Benjamin; Wick, Wolfgang; Ziemer, Mirjana; Zimmer, Lisa; Garbe, Claus; Schadendorf, Dirk
    S3 Guideline for the Diagnosis, Therapy and Follow‐Up of Malignant Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. 10, S. 1079 – 1208
    DOI (Open Access)
  • Kähler, Katharina C.; Hassel, Jessica C.; Heinzerling, Lucie; Loquai, Carmen; Thoms, Kai-Martin; Ugurel, Selma; Zimmer, Lisa; Gutzmer, Ralf
    Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma – an update
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. 6, S. 582 – 609
    DOI (Open Access)
  • Ugurel, Selma; Röhmel, Joachim; Ascierto, Paolo A.; Becker, Jürgen C.; Flaherty, Keith T.; Grob, Jean J.; Hauschild, Axel; Larkin, James; Livingstone, Elisabeth; Long, Georgina V.; Lorigan, Paul; McArthur, Grant A.; Ribas, Antoni; Robert, Caroline; Zimmer, Lisa; Schadendorf, Dirk; Garbe, Claus
    Survival of patients with advanced metastatic melanoma : The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
    In: European Journal of Cancer (EJC) , Jg. 130 2020, S. 126 – 138
    DOI
  • Matsuya, Taisuke; Nakamura, Yasuhiro; Matsushita, Shigeto; Tanaka, Ryota; Teramoto, Yukiko; Asami, Yuri; Uehara, Jiro; Aoki, Megumi; Yamamura, Kentaro; Nakamura, Yoshiyuki; Fujisawa, Yasuhiro; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Kagamu, Hiroshi; Fujimoto, Manabu; Honma, Masaru; Ishida-Yamamoto, Akemi; Araki, Ryuichiro; Yamamoto, Akifumi
    Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma : A multi-institutional retrospective study
    In: The Journal of Dermatology , Jg. 47 2020, Nr. 6, S. 629 – 635
    DOI
  • Heinzerling, Lucie; de Toni, Enrico N.; Schett, Georg; Hundorfean, Gheorghe; Zimmer, Lisa
    Checkpoint Inhibitors : The diagnosis and treatment of side effects
    In: Deutsches Ärzteblatt international , Jg. 116 2019, Nr. 8, S. 119 – 126
    DOI (Open Access)
  • Zaremba, Anne; Murali, Rajmohan; Jansen, Philipp; Möller, Inga; Sucker, Antje; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Brinker, Titus J.; Hadaschik, Eva; Franklin, Cindy; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus; Cosgarea, Ioana
    Clinical and genetic analysis of melanomas arising in acral sites
    In: European Journal of Cancer (EJC) , Jg. 119 2019, S. 66 – 76
    DOI (Open Access)
  • Drago, Joshua Z.; Lawrence, Donald; Livingstone, Elisabeth; Zimmer, Lisa; Chen, Tianqi; Giobbie-Hurder, Anita; Amann, Valerie C.; Mangana, Joanna; Siano, Marco; Zippelius, Alfred; Dummer, Reinhard; Goldinger, Simone M.; Sullivan, Ryan J.
    Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases : a real-life multicenter study
    In: Melanoma Research , Jg. 29 2019, Nr. 1, S. 65 – 69
    DOI (Open Access)
  • Heppt, Markus V.; Amaral, Teresa; Kähler, Katharina C.; Heinzerling, Lucie; Hassel, Jessica C.; Meissner, Markus; Kreuzberg, Nicole; Loquai, Carmen; Reinhardt, Lydia; Utikal, Jochen; Dabrowski, Evelyn; Gesierich, Anja; Pföhler, Claudia; Terheyden, Patrick; Thoms, Kai-Martin; Zimmer, Lisa; Eigentler, Thomas K.; Kirchberger, Michael C.; Stege, Henner M.; Meier, Friedegund; Schlaak, Max; Berking, Carola
    Combined immune checkpoint blockade for metastatic uveal melanoma : a retrospective, multi-center study
    In: Journal for ImmunoTherapy of Cancer , Jg. 7 2019, Nr. 1 , Article-No: 299
    DOI (Open Access)
  • Ugurel, Selma; Schadendorf, Dirk; Sucker, A.; Schramm, Sara; Utikal, J.; Pfohler, C.; Herbst, R.; Schilling, Bastian; Blank, C.; Becker, J. C.; Paschen, Annette; Zimmer, Lisa; Livingstone, Elisabeth; Horn, Peter; Rebmann, Vera
    High PD-1 or PD-L1 Concentrations in the Serum of Melanoma Patients are predictive for reduced Therapeutic Success of PD-1 Inhibition
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 17 2019, Nr. Suppl. 5, S. 7 – 7
  • Kanaki, Theodora; Stang, Andreas; Gutzmer, Ralf; Zimmer, Lisa; Chorti, Eleftheria; Sucker, Antje; Ugurel, Selma; Hadaschik, Eva; Gräger, Nikolai S.; Satzger, Imke; Schadendorf, Dirk; Livingstone, Elisabeth
    Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma
    In: European Journal of Cancer (EJC) , Jg. 119 2019, S. 18 – 29
    DOI
  • Rauschenberg, Ricarda; Bruns, Johannes; Brütting, Julia; Daubner, Dirk; Lohaus, Fabian; Zimmer, Lisa; Forschner, Andrea; Zips, Daniel; Hassel, Jessica C.; Berking, Carola; Kaehler, Katharina C.; Utikal, Jochen; Gutzmer, Ralf; Terheyden, Patrik; Meiss, Frank; Rafei-Shamsabadi, David; Kiecker, Felix; Debus, Dirk; Dabrowski, Evelyn; Arnold, Andreas; Garzarolli, Marlene; Kuske, Marvin; Beissert, Stefan; Löck, Steffen; Linn, Jennifer; Troost, Esther G.C.; Meier, Friedegund
    Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases
    In: European Journal of Cancer (EJC) , Jg. 110 2019, S. 11 – 20
    DOI (Open Access)
  • Liu, David; Schilling, Bastian; Liu, Derek; Sucker, Antje; Livingstone, Elisabeth; Jerby-Amon, Livnat; Zimmer, Lisa; Gutzmer, Ralf; Satzger, Imke; Loquai, Carmen; Grabbe, Stephan; Vokes, Natalie; Margolis, Claire A.; Conway, Jake; He, Meng Xiao; Elmarakeby, Haitham; Dietlein, Felix; Miao, Diana; Tracy, Adam; Gogas, Helen; Goldinger, Simone M.; Utikal, Jochen; Blank, Christian U.; Rauschenberg, Ricarda; Bubnoff, Dagmar von; Krackhardt, Angela; Weide, Benjamin; Haferkamp, Sebastian; Kiecker, Felix; Izar, Ben; Garraway, Levi; Regev, Aviv; Flaherty, Keith; Paschen, Annette; Allen, Eliezer M. van; Schadendorf, Dirk
    Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
    In: Nature Medicine , Jg. 25 2019, Nr. 12, S. 1916 – 1927
    DOI (Open Access)
  • Ugurel, Selma; Spassova, Ivelina; Wohlfarth, Jonas; Drusio, Christina; Cherouny, Angela; Melior, Anita; Sucker, Antje; Zimmer, Lisa; Ritter, Cathrin; Schadendorf, Dirk; Becker, Jürgen
    MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition : a case series
    In: Cancer Immunology, Immunotherapy , Jg. 68 2019, Nr. 6, S. 983 – 990
    DOI (Open Access)
  • Khoja, L.; Atenafu, E.G.; Suciu, S.; Leyvraz, S.; Sato, T.; Marshall, E.; Keilholz, U.; Zimmer, Lisa; Patel, S.P.; Piperno-Neumann, S.; Piulats, J.; Kivelä, T.T.; Pfoehler, C.; Bhatia, S.; Huppert, P.; Van Iersel, L.B.J.; De Vries, I.J.M.; Penel, N.; Vogl, T.; Cheng, T.; Fiorentini, G.; Mouriaux, F.; Tarhini, A.; Patel, P.M.; Carvajal, R.; Joshua, A.M.
    Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks : An international rare cancers initiative (IRCI) ocular melanoma study
    In: Annals of Oncology , Jg. 30 2019, Nr. 8, S. 1370 – 1380
    DOI (Open Access)
  • Zaremba, Anne; Chorti, Eleftheria; Jockenhöfer, Finja; Bolz, Saskia; Sirin, Selma; Glas, Martin; Becker, Jürgen C.; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth; Hagenacker, Tim; Zimmer, Lisa
    Metastatic Merkel cell carcinoma and myasthenia gravis : contraindication for therapy with immune checkpoint inhibitors?
    In: Journal for ImmunoTherapy of Cancer , Jg. 7 2019, Nr. 1, S. 141
    DOI, Online Volltext (Open Access)
  • Moreira, Alvaro; Loquai, Carmen; Pföhler, Claudia; Kähler, Katharina C.; Knauss, Samuel; Heppt, Markus V.; Gutzmer, Ralf; Dimitriou, Florentia; Meier, Friedegund; Mitzel-Rink, Heidrun; Schuler, Gerold; Terheyden, Patrick; Thoms, Kai-Martin; Türk, Matthias; Dummer, Reinhard; Zimmer, Lisa; Schröder, Rolf; Heinzerling, Lucie
    Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors
    In: European Journal of Cancer (EJC) , Jg. 106 2019, S. 12 – 23
    DOI
  • Urbonas, Vincas; Schadendorf, Dirk; Zimmer, Lisa; Danson, Sarah J.; Marshall, Ernest; Corrie, Pippa G.; Wheater, Matthew J.; Plummer, E.; Mauch, Cornelia; Scudder, Claire; Goff, Matthew; Love, Sharon B.; Mohammed, S.B.; Middleton, Mark R.
    Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL) : a multicentre, open-label, randomised, controlled phase II trial
    In: Annals of Oncology , Jg. 30 2019, Nr. 2, S. 317 – 324
    DOI (Open Access)
  • Viehof, Jan; Livingstone, Elisabeth; Loscha, Elena; Stockhammer, Paul; Bankfalvi, Agnes; Plönes, Till; Mardanzai, Khaled; Zimmer, Lisa; Sucker, Antje; Schadendorf, Dirk; Hegedüs, Balazs; Aigner, Clemens
    Prognostic factors for pulmonary metastasectomy in malignant melanoma : Size matters
    In: European Journal of Cardio-Thoracic Surgery , Jg. 56 2019, Nr. 6, S. 1104 – 1109
    DOI (Open Access)
  • Shannan, B.; Matschke, Johann; Chauvistré, Heike; Vogel, F.; Klein, Diana; Meier, Friedegund; Westphal, Dana; Bruns, Johannes; Rauschenberg, Ricarda; Utikal, Jochen; Forschner, Andrea; Berking, Carola; Terheyden, Patrick; Dabrowski, Evelyn; Gutzmer, Ralf; Rafei-Shamsabadi, David Ali; Meiss, Frank; Heinzerling, Lucie M.; Zimmer, Lisa; Livingstone, Elisabeth; Váraljai, Renáta; Hoewner, A.; Horn, Susanne; Klode, Joachim; Stuschke, Martin; Scheffler, Björn; Marchetto, Aruna; Sannino, Giuseppina; Grünewald, Thomas Georg Philipp; Schadendorf, Dirk; Jendrossek, Verena; Rösch, Alexander
    Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV⁶⁰⁰E inhibition in melanoma
    In: European Journal of Cancer (EJC) , Jg. 109 2019, S. 137 – 153
    DOI
  • Stoppek, Ann-Kathrin; Kebir, Sied; Junker, Andreas; Keyvani, Kathy; Zülow, Stefan; Lazaridis, Lazaros; Schmidt, Teresa; Pierscianek, Daniela; Stuschke, Martin; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Zimmer, Lisa; Glas, Martin
    Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report
    In: BMC Cancer , Jg. 19 2019, Nr. 1, S. 995
    DOI, Online Volltext (Open Access)
  • Menzer, Christian; Menzies, Alexander M.; Carlino, Matteo S.; Reijers, Irene; Groen, Emma J.; Eigentler, Thomas; de Groot, Jan Willem B; van der Veldt, Astrid A M; Johnson, Douglas B.; Meiss, Frank; Schlaak, Max; Schilling, Bastian; Westgeest, Hans M.; Gutzmer, Ralf; Pföhler, Claudia; Meier, Friedegund; Zimmer, Lisa; Suijkerbuijk, Karijn P M; Haalck, Thomas; Thoms, Kai-Martin; Herbschleb, Karin; Leichsenring, Jonas; Menzer, Alexander; Kopp-Schneider, Annette; Long, Georgina V.; Kefford, Richard; Enk, Alexander; Blank, Christian U.; Hassel, Jessica C.
    Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 33, S. 3142 – 3151
    DOI (Open Access)
  • Heinzerling, Lucie; Eigentler, Thomas K.; Fluck, Michael; Hassel, Jessica C.; Heller-Schenck, Daniela; Leipe, Jan; Pauschinger, Matthias; Vogel, Arndt; Zimmer, Lisa; Gutzmer, Ralf
    Tolerability of BRAF/MEK inhibitor combinations : Adverse event evaluation and management
    In: ESMO Open , Jg. 4 2019, Nr. 3, S. e000491
    DOI (Open Access)
  • Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Treatment in metastatic melanoma : Time to re-think
    In: Annals of Oncology , Jg. 30 2019, Nr. 4, S. 501 – 503
    DOI (Open Access)
  • Tio, Martin; Rai, Rajat; Ezeoke, Ogochukwu M.; McQuade, Jennifer L.; Zimmer, Lisa; Khoo, Chloe; Park, John J.; Spain, Lavinia; Turajlic, Samra; Ardolino, Luke; Yip, Desmond; Goldinger, Simone M.; Cohen, Justine V.; Millward, Michael; Atkinson, Victoria; Kane, Alisa Y.; Ascierto, Paolo A.; Garbe, Claus; Gutzmer, Ralf; Johnson, Douglas B.; Rizvi, Hira A.; Joshua, Anthony M.; Hellmann, Matthew D.; Long, Georgina V.; Menzies, Alexander M.
    Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection
    In: European Journal of Cancer (EJC) , Jg. 104 2018, S. 137 – 144
    DOI (Open Access)
  • Hecht, Markus; Meier, Friedegund; Zimmer, Lisa; Polat, Bülent; Loquai, Carmen; Weishaupt, Carsten; Forschner, Andrea; Gutzmer, Ralf; Utikal, Jochen S.; Goldinger, Simone M.; Geier, Michael; Hassel, Jessica C.; Balermpas, Panagiotis; Kiecker, Felix; Rauschenberg, Ricarda; Dietrich, Ursula; Clemens, Patrick; Berking, Carola; Grabenbauer, Gerhard; Schadendorf, Dirk; Grabbe, Stephan; Schuler, Gerold; Fietkau, Rainer; Distel, Luitpold V.; Heinzerling, Lucie
    Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients
    In: British Journal of Cancer (BJC) , Jg. 118 2018, Nr. 6, S. 785 – 792
    DOI (Open Access)
  • Olischewsky, Alexandra; De Schrijver, Sofie; Bankfalvi, Agnes; Wetter, Axel; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Dose-dependent toxicity of ipilimumab in metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 95 2018, S. 104 – 108
    DOI
  • Kähler, Katharina C.; Eigentler, Thomas K.; Gesierich, Anja; Heinzerling, Lucie; Loquai, Carmen; Meier, Friedegund; Meiss, Frank; Pföhler, Claudia; Schlaak, Max; Terheyden, Patrick; Thoms, Kai M.; Ziemer, Mirjana; Zimmer, Lisa; Gutzmer, Ralf; German Dermatologic Cooperative Oncology Group (DeCOG)
    Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders
    In: Cancer Immunology, Immunotherapy , Jg. 67 2018, Nr. 5, S. 825 – 834
    DOI
  • Milsch, Laura; Gesierich, Anja; Kreft, Sophia; Livingstone, Elisabeth; Zimmer, Lisa; Goebeler, Matthias; Schadendorf, Dirk; Schilling, Bastian
    Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade
    In: European Journal of Cancer (EJC) , Jg. 99 2018, S. 58 – 65
    DOI
  • Hassel, Jessica C.; Buder-Bakhaya, Kristina; Bender, Carolin; Zimmer, Lisa; Weide, Benjamin; Loquai, Carmen; Ugurel, Selma; Slynko, Alla; Gutzmer, Ralf
    Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma
    In: Cancer Medicine , Jg. 7 2018, Nr. 1, S. 95 – 104
    DOI (Open Access)
  • Jockenhöfer, Finja; Schimming, Tobias T.; Schaller, Jörg; Moege, Jürgen; Livingstone, Elisabeth; Salva, Katrin A.; Zimmer, Lisa; Schadendorf, Dirk; Rösch, Alexander
    Sebaceous tumours: more than skin deep
    In: Gut , Jg. 67 2018, Nr. 11, S. 2045 – 2053
    DOI
  • Tietze, Julia K.; Forschner, Andrea; Loquai, Carmen; Mitzel-Rink, Heidrun; Zimmer, Lisa; Meiss, Frank; Rafei-Shamsabadi, David; Utikal, Jochen; Bergmann, Maike; Meier, Friedegund; Kreuzberg, Nicole; Schlaak, Max; Weishaupt, Carsten; Pföhler, Claudia; Ziemer, Mirjana; Fluck, Michael; Rainer, Jessica; Heppt, Markus V.; Berking, Carola
    The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma : A retrospective multicenter study
    In: OncoTarget , Jg. 9 2018, Nr. 76, S. 34336 – 34346
    DOI (Open Access)
  • Knispel, Sarah; Zimmer, Lisa; Kanaki, Theodora; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth
    The safety and efficacy of dabrafenib and trametinib for the treatment of melanoma
    In: Expert Opinion on Drug Safety , Jg. 17 2018, Nr. 1, S. 73 – 87
    DOI
  • Hassel, Jessica C.; Heinzerling, Lucie; Aberle, Jens; Bähr, Oliver; Eigentler, Thomas K.; Grimm, Marc-Oliver; Grünwald, Victor; Leipe, Jan; Reinmuth, Niels; Tietze, Julia K.; Trojan, Jörg; Zimmer, Lisa; Gutzmer, Ralf
    Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4) : Evaluation and management of adverse drug reactions
    In: Cancer Treatment Reviews , Jg. 57 2017, S. 36 – 49
    DOI
  • Franklin, Cindy; Rooms, Isabelle; Fiedler, Melanie; Reis, Henning; Milsch, Laura; Herz, Saskia; Livingstone, Elisabeth; Zimmer, Lisa; Schmid, Kurt Werner; Dittmer, Ulf; Schadendorf, Dirk; Schilling, Bastian
    Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis
    In: European Journal of Cancer (EJC) , Jg. 86 2017, S. 248 – 256
    DOI
  • Ugurel, Selma; Kiecker, Felix; Fröhling, Stefan; Wetter, Axel; Bankfalvi, Agnes; Sucker, Antje; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Becker, Jürgen; Schadendorf, Dirk
    Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma
    In: European Journal of Cancer (EJC) , Jg. 83 2017, S. 142 – 145
    DOI
  • Potrony, Miriam; Rebollo-Morell, Aida; Giménez-Xavier, Pol; Zimmer, Lisa; Puig-Butille, Joan Anton; Tell-Marti, Gemma; Sucker, Antje; Badenas, Celia; Carrera, Cristina; Malvehy, Josep; Schadendorf, Dirk; Puig, Susana
    IRF4 rs12203592 functional variant and melanoma survival
    In: International Journal of Cancer , Jg. 140 2017, Nr. 8, S. 1845 – 1849
    DOI
  • Zimmer, Lisa; Apuri, Susmitha; Eroglu, Zeynep; Kottschade, Lisa A.; Forschner, Andrea; Gutzmer, Ralf; Schlaak, Max; Heinzerling, Lucie; Krackhardt, Angela M.; Loquai, Carmen; Markovic, Svetomir N.; Joseph, Richard W.; Markey, Kelly; Utikal, Jochen S.; Weishaupt, Carsten; Goldinger, Simone M.; Sondak, Vernon K.; Zager, Jonathan S.; Schadendorf, Dirk; Khushalani, Nikhil I.
    Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
    In: European Journal of Cancer (EJC) , Jg. 75 2017, S. 47 – 55
    DOI
  • Gutzmer, Ralf; Koop, Anika; Meier, Friedegund; Hassel, Jessica C.; Terheyden, Patrick; Zimmer, Lisa; Heinzerling, Lucie; Ugurel, Selma; Pföhler, Claudia; Gesierich, Anja; Livingstone, Elisabeth; Satzger, Imke; Kähler, Katharina C.
    Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
    In: European Journal of Cancer (EJC) , Jg. 75 2017, S. 24 – 32
    DOI
  • Strobel, Sophia Boyoung; Pätzold, Sylvie; Zimmer, Lisa; Jensen, Alexandra; Enk, Alexander; Hassel, Jessica Cecile
    Radiosensibilisierung durch BRAF Inhibitoren
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 15 2017, Nr. 7, S. 703 – 708
    DOI
  • Strobel, Sophia Boyoung; Pätzold, Sylvie; Zimmer, Lisa; Jensen, Alexandra; Enk, Alexander; Hassel, Jessica Cecile
    Radiosensitization by BRAF inhibitors
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 15 2017, Nr. 7, S. 703 – 708
    DOI
  • Griewank, Klaus; Müller, Hansgeorg; Jackett, Louise A.; Emberger, Michael; Möller, Inga; van de Nes, Johannes; Zimmer, Lisa; Livingstone, Elisabeth; Wiesner, Thomas; Scholz, Simone L.; Cosgarea, Ioana; Sucker, Antje; Schimming, Tobias; Hillen, Uwe; Schilling, Bastian; Paschen, Annette; Reis, Henning; Mentzel, Thomas; Kutzner, Heinz; Rütten, Arno; Murali, Rajmohan; Scolyer, Richard A.; Schadendorf, Dirk
    SF3B1 and BAP1 mutations in blue nevus-like melanoma
    In: Modern Pathology , Jg. 30 2017, Nr. 7, S. 928 – 939
    DOI (Open Access)
  • Cosgarea, Ioana; Ugurel, Selma; Sucker, Antje; Livingstone, Elisabeth; Zimmer, Lisa; Ziemer, Mirjana; Utikal, Jochen; Mohr, Peter; Pfeiffer, Christiane; Pföhler, Claudia; Hillen, Uwe; Horn, Susanne; Schadendorf, Dirk; Griewank, Klaus; Rösch, Alexander
    Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
    In: OncoTarget , Jg. 8 2017, Nr. 25, S. 40683 – 40692
    DOI (Open Access)
  • Hofmann, Lars; Heinzerling, Lucie M.; Dummer, Reinhard; Schuler, Gerold; Schadendorf, Dirk; Krackhardt, Angela M.; Gesierich, Anja; Berking, Carola; Eigentler, Thomas; Kirchberger, Michael C.; Garbe, Claus; Dietrich, Ursula; Wahl, Renate; Leverkus, Martin; Weishaupt, Carsten; Thomas, Ioannis; Tietze, Julia K.; Meier, Friedegund; Hassel, Jessica C.; Göppner, Daniela; Utikal, Jochen S.; Gutzmer, Ralf; Schmidgen, Maria I.; Ugurel, Selma; Zimmer, Lisa; Goldinger, Simone M.; Loquai, Carmen; Forschner, Andrea
    Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
    In: European Journal of Cancer (EJC) , Jg. 60 2016, S. 190 – 209
    DOI
  • Eigentler, Thomas K; Hassel, Jessica C; Berking, Carola; Aberle, Jens; Bachmann, Oliver; Grünwald, Viktor; Kähler, Katharina C; Loquai, Carmen; Reinmuth, Niels; Steins, Martin; Zimmer, Lisa; Sendl, Anna; Gutzmer, Ralf
    Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy
    In: Cancer Treatment Reviews , Jg. 45 2016, S. 7 – 18
    DOI
  • Huebner, Jutta; Mohr, Peter; Simon, Jan-Christoph; Fluck, Michael; Berking, Carola; Zimmer, Lisa; Loquai, Carmen
    Gebrauch von Komplementärmedizin bei Patienten mit metastasierendem Melanom unter Therapie mit Ipilimumab innerhalb einer klinischen Studie
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 14 2016, Nr. 5, S. 508 – 513
    DOI
  • Potrony, Miriam; Carreras, Esther; Aranda, Fernando; Zimmer, Lisa; Puig-Butille, Joan-Anton; Tell-Martí, Gemma; Armiger, Noelia; Sucker, Antje; Giménez-Xavier, Pol; Martínez-Florensa, Mario; Carrera, Cristina; Malvehy, Josep; Schadendorf, Dirk; Puig, Susana; Lozano, Francisco
    Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival
    In: International Journal of Cancer , Jg. 139 2016, Nr. 6, S. 1297 – 1302
    DOI (Open Access)
  • Sondermann, Wiebke; Zimmer, Lisa; Schadendorf, Dirk; Rösch, Alexander; Klode, Joachim; Dissemond, Joachim
    Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis
    In: Medicine , Jg. 95 2016, Nr. 29, S. e4332
    DOI (Open Access)
  • Kähler, Katharina C.; Hassel, Jessica C.; Heinzerling, Lucie; Loquai, Carmen; Mössner, Rotraut; Ugurel, Selma; Zimmer, Lisa; Gutzmer, Ralf
    Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 14 2016, Nr. 7, S. 662 – 681
    DOI
  • Livingstone, Elisabeth; Rösch, Alexander; Schadendorf, Dirk; Zimmer, Lisa; Schilling, Bastian
    Medikamentöse Therapie des metastasierten malignen Melanoms
    In: Arzneimitteltherapie (AMT) , Jg. 34 2016, Nr. 1-2, S. 14 – 22
  • Kähler, Katharina C.; Hassel, Jessica C.; Heinzerling, Lucie; Loquai, Carmen; Mössner, Rotraut; Ugurel, Selma; Zimmer, Lisa; Gutzmer, Ralf
    Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD1-Antikörper beim metastasierten Melanom
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 14 2016, Nr. 7, S. 662 – 683
    DOI
  • Zimmer, Lisa; Heinzerling, Lucie M.; Dummer, Reinhard; Schuler, Gerold; Schadendorf, Dirk; Krackhardt, Angela M.; Gesierich, Anja; Berking, Carola; Eigentler, Thomas; Kirchberger, Michael C.; Garbe, Claus; Dietrich, Ursula; Wahl, Renate; Leverkus, Martin; Weishaupt, Carsten; Forschner, Andrea; Tietze, Julia K.; Meier, Friedegund; Hassel, Jessica C.; Göppner, Marian-Daniela; Utikal, Jochen S.; Gutzmer, Ralf; Schmidgen, Maria I.; Thomas, Ioannis; Ugurel, Selma; Loquai, Carmen; Hofmann, Lars; Goldinger, Simone M.
    Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
    In: European Journal of Cancer (EJC) , Jg. 60 2016, S. 210 – 225
    DOI
  • Griewank, Klaus; Schilling, Bastian; Scholz, Simone L; Metz, Claudia H; Livingstone, Elisabeth; Sucker, Antje; Möller, Inga; Reis, Henning; Franklin, Cindy; Cosgarea, Ioana; Hillen, Uwe; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Zimmer, Lisa
    Oncogene status as a diagnostic tool in ocular and cutaneous melanoma
    In: European Journal of Cancer (EJC) , Jg. 57 2016, S. 112 – 117
    DOI
  • van de Nes, Johannes; Gessi, Marco; Sucker, Antje; Möller, Inga; Stiller, Mathias; Horn, Susanne; Scholz, Simone L.; Pischler, Carina; Stadtler, Nadine; Schilling, Bastian; Zimmer, Lisa; Hillen, Uwe; Scolyer, Richard A.; Buckland, Michael E.; Lauriola, Libero; Pietsch, Torsten; Waha, Andreas; Schadendorf, Dirk; Murali, Rajmohan; Griewank, Klaus
    Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system
    In: Journal of Neuro-Oncology , Jg. 127 2016, Nr. 3, S. 435 – 444
    DOI (Open Access)
  • Ugurel, Selma; Loquai, Carmen; Kähler, Katharina; Hassel, Jessica; Berking, Carola; Zimmer, Lisa; Haubitz, Imme; Satzger, Imke; Müller-Brenne, Tina; Mikhaimer, Nadia C.; Becker, Jürgen; Kilian, Katharina J.; Schadendorf, Dirk; Heinzerling, Lucie; Kaatz, Martin; Utikal, Jochen; Göppner, Daniela; Pföhler, Claudia; Pflugfelder, Annette; Mößner, Rotraut; Gutzmer, Ralf
    A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma : pretreatment impacts survival
    In: Annals of Oncology , Jg. 26 2015, Nr. 3, S. 573 – 582
    DOI (Open Access)
  • Johnson, Douglas B.; Schadendorf, Dirk; Egberts, Friederike; Berking, Carola; Becker, Jürgen; Gutzmer, Ralf; Gogask, Helen; Scolyer, Richard A.; Sucker, Antje; Rizos, Helen; Zhao, Shilin; Eroglu, Zeynep; Zimmer, Lisa; Menzies, Alexander M.
    Acquired BRAF inhibitor resistance : A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
    In: European Journal of Cancer (EJC) , Jg. 51 2015, Nr. 18, S. 2792 – 2799
    DOI (Open Access)
  • Scholz, Simone L.; Horn, Susanne; Murali, Rajmohan; Möller, Inga; Sucker, Antje; Sondermann, Wiebke; Stiller, Mathias; Schilling, Bastian; Livingstone, Elisabeth; Zimmer, Lisa; Reis, Henning; Metz, Claudia H; Zeschnigk, Michael; Paschen, Annette; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Analysis of SDHD promoter mutations in various types of melanoma
    In: OncoTarget , Jg. 6 2015, Nr. 28, S. 25868 – 25882
    DOI (Open Access)
  • Scholz, S.; Horn, S.; Murali, R.; Moeller, I.; Sucker, A.; Sondermann, W.; Stiller, Mathias; Schilling, Bastian; Livingstone, Elisabeth; Zimmer, Lisa; Reis, Henning; Metz, C.; Zeschnigk, Michael; Paschen, Annette; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Griewank, Klaus
    Analysis of SDHD promoter mutations in various types of melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 13 2015, Nr. Suppl. 2, S. 11
    DOI
  • Tolk, Henrike; Satzger, Imke; Mohr, Peter; Zimmer, Lisa; Weide, Benjamin; Schäd, Susanne; Gutzmer, Ralf
    Complete remission of metastatic melanoma upon BRAF inhibitor treatment - what happens after discontinuation?
    In: Melanoma Research , Jg. 25 2015, Nr. 4, S. 362 – 366
    DOI
  • Sondermann, Wiebke; Griewank, Klaus; Schilling, Bastian; Livingstone, Elisabeth; Leyh, Julia C.; Rompoti, Natalia; Cosgarae, Ioana; Schimming, Tobias; Schadendorf, Dirk; Zimmer, Lisa; Hillen, Uwe
    Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of Infection
    In: PLoS ONE , Jg. 10 2015, Nr. 4, S. e0124590
    DOI (Open Access)
  • Mössner, Rotraut; Zimmer, Lisa; Berking, Carola; Höeller, Christoph; Loquai, Carmen; Richtig, Erika; Kähler, Katharina Charlotte; Hassel, Jessica Cecile Ecile; Gutzmer, Ralf; Ugurel, Selma
    Erythema nodosum-like lesions during BRAF inhibitor therapy : report on 16 new cases and review of the literature
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 29 2015, Nr. 9, S. 1797 – 1806
    DOI
  • Van Allen, Eliezer M; Miao, Diana; Schilling, Bastian; Shukla, Sachet A; Blank, Christian; Zimmer, Lisa; Sucker, Antje; Hillen, Uwe; Foppen, Marnix H Geukes; Goldinger, Simone M; Utikal, Jochen; Hassel, Jessica C; Weide, Benjamin; Kaehler, Katharina C; Loquai, Carmen; Mohr, Peter; Gutzmer, Ralf; Dummer, Reinhard; Gabriel, Stacey; Wu, Catherine J; Schadendorf, Dirk; Garraway, Levi A
    Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
    In: Science , Jg. 350 2015, Nr. 6257, S. 207 – 211
    DOI (Open Access)
  • Zimmer, Lisa; Schadendorf, Dirk; Garbe, Claus; Assi, Zeinab; Loquai, Carmen; Rompel, Rainer; Terheyden, Patrick; Fluck, Michael F Z; Hauschild, Axel; Stadler, Rudolf; Dippel, Edgar; Kämpgen, Eckhart; Berking, Carola; Mohr, Peter E.; Utikal, Jochen; Simon, Jan Christoph; Kiecker, Felix; Eigentler, Thomas Kurt
    Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
    In: Journal of Translational Medicine , Jg. 13 2015, Nr. 1, S. 351
    DOI (Open Access)
  • Zimmer, Lisa; Vaubel, Julia Marianne; Mohr, Peter; Hauschild, Axel; Utikal, Jochen; Simon, Jan; Garbe, Claus; Herbst, Rudolf; Enk, Alexander; Kämpgen, Eckhart; Livingstone, Elisabeth; Bluhm, Leonie; Rompel, Rainer; Griewank, Klaus; Fluck, Michael; Schilling, Bastian; Schadendorf, Dirk
    Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
    In: PLoS ONE , Jg. 10 2015, Nr. 3, S. e0118564
    DOI (Open Access)
  • Hecht, Markus; Zimmer, Lisa; Loquai, Carmen; Weishaupt, Carsten; Gutzmer, Ralf; Schuster, B.; Gleisner, S.; Schulze, Björn; Goldinger, S. M.; Berking, Carola; Forschner, Andrea; Clemens, P.; Grabenbauer, Gerhard; Müller-Brenne, Tina; Bauch, Julia; Eich, Hans T.; Grabbe, Stephan; Schadendorf, Dirk; Schuler, Gerold; Keikavoussi, Petra; Semrau, S.; Fietkau, Rainer; Distel, Luitpold V.; Heinzerling, Lucie
    Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients
    In: Annals of Oncology , Jg. 26 2015, Nr. 6, S. 1238 – 1244
    DOI (Open Access)
  • Schilling, Bastian; Sondermann, Wiebke; Griewank, Klaus; Livingstone, Elisabeth; Zimmer, Lisa; Hillen, Uwe; Schadendorf, Dirk
    Reply to the letters to the editor ‘Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma’ by Diwakar et al.
    In: Annals of Oncology , Jg. 26 2015, Nr. 1, S. 250 – 251
    DOI
  • Schadendorf, Dirk; Livingstone, Elisabeth; Schilling, Bastian; Rösch, Alexander; Zimmer, Lisa
    Therapie des malignen Melanoms
    In: Der Onkologe , Jg. 21 2015, Nr. 10, S. 965 – 974
    DOI
  • Schilling, Bastian; Sondermann, W.; Zhao, F.; Griewank, Klaus; Livingstone, Elisabeth; Sucker, A.; Zelba, H.; Weide, B.; Trefzer, U.; Wilhelm, T.; Loquai, C.; Berking, C.; Hassel, J.; Kähler, K. C.; Utikal, J.; Al~ghazal, P.; Gutzmer, R.; Goldinger, S. M.; Zimmer, Lisa; Paschen, Annette; Hillen, Uwe; Schadendorf, Dirk
    Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma
    In: Annals of Oncology , Jg. 25 2014, Nr. 3, S. 747 – 753
    DOI
  • Griewank, Klaus; van de Nes, Johannes; Schilling, Bastian; Moll, Iris; Sucker, Antje; Kakavand, Hojabr; Haydu, Lauren E; Asher, Marina; Zimmer, Lisa; Hillen, Uwe; Thompson, John F; Scolyer, Richard A; Schadendorf, Dirk; Murali, Rajmohan
    Genetic and clinico-pathologic analysis of metastatic uveal melanoma
    In: Modern Pathology , Jg. 27 2014, Nr. 2, S. 175 – 183
    DOI
  • Zimmer, Lisa; Haydu, Lauren E; Menzies, Alexander M; Scolyer, Richard A; Kefford, Richard F; Thompson, John F; Schadendorf, Dirk; Long, Georgina V
    Incidence of new primary melanomas after diagnosis of stage III and IV melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 8, S. 816 – 823
    DOI
  • Gutzmer, Ralf; Hassel, J. C.; Kähler, K. C.; Loquai, C.; Mössner, R.; Ugurel, Selma; Zimmer, Lisa
    Kutane Nebenwirkungen der medikamentösen Tumortherapie mit BRAF- und MEK-Inhibitoren
    In: Der Hautarzt , Jg. 65 2014, Nr. 7, S. 582 – 589
    DOI
  • Zimmer, Lisa; Barlesi, Fabrice; Martinez-Garcia, Maria; Dieras, Veronique; Schellens, Jan. H.M.; Spano, Jean-Phillipe; Middleton, Marc R.; Calvo, Emiliano; Paz-Ares, Luiz; Larkin, James; Pacey, Simon; Venturi, Miro; Kraeber-Bodéré, Francoise; Tessier, Jean J. L.; Eberhardt, Wilfried; Paques, Michel; Guarin, Ernesto; Meresse, Valerie; Soria, Jean-Charles
    Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations
    In: Clinical Cancer Research , Jg. 20 2014, Nr. 16, S. 4251 – 4261
    DOI
  • Zimmer, Lisa; Haydu, Lauren E; Menzies, Alexander M; Scolyer, Richard A; Kefford, Richard F; Thompson, John F; Schadendorf, Dirk; Long, Georgina V
    Reply to M. Perier-Muzet et al [Safety and Management of New Primary Melanomas During Receipt of BRAF Inhibitors ]
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 28, S. 3203 – 3204
    DOI
  • Vaubel, Julia Marianne; Livingstone, Elisabeth; Schadendorf, Dirk; Zimmer, Lisa
    Retarded low-dose doxycycline for EGFR or MEK inhibitor-induced papulopustular rash
    In: Journal of the European Academy of Dermatology and Venereology , Jg. 28 2014, Nr. 12, S. 1685 – 1689
    DOI
  • Griewank, Klaus; Murali, Rajmohan; Puig-Butille, Joan Anton; Schilling, Bastian; Livingstone, Elisabeth; Potrony, Miriam; Carrera, Cristina; Schimming, Tobias; Möller, Inga; Schwamborn, Marion; Sucker, Antje; Hillen, Uwe; Badenas, Celia; Malvehy, Josep; Zimmer, Lisa; Scherag, Andre; Puig, Susanne; Schadendorf, Dirk
    TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma
    In: Journal of the National Cancer Institute (JNCI) , Jg. 106 2014, Nr. 9
    DOI
  • Griewank, Klaus; Schilling, Bastian; Murali, Rajmohan; Bielefeld, Nicola; Schwamborn, Marion; Sucker, Antje; Zimmer, Lisa; Hillen, Uwe; Schaller, Jörg; Brenn, Thomas; Schadendorf, Dirk; Mentzel, Thomas
    TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas
    In: Modern Pathology , Jg. 27 2014, Nr. 4, S. 502 – 508
    DOI (Open Access)
  • Van Allen, Eliezer M; Wagle, Nikhil; Sucker, Antje; Treacy, Daniel J; Johannessen, Cory M; Goetz, Eva M; Place, Chelsea S; Taylor-Weiner, Amaro; Whittaker, Steven; Kryukov, Gregory V; Hodis, Eran; Rosenberg, Mara; McKenna, Aaron; Cibulskis, Kristian; Farlow, Deborah; Zimmer, Lisa; Hillen, Uwe; Gutzmer, Ralf; Goldinger, Simone M; Ugurel, Selma; Gogas, Helen J; Egberts, Friederike; Berking, Carola; Trefzer, Uwe; Loquai, Carmen; Weide, Benjamin; Hassel, Jessica C; Gabriel, Stacey B; Carter, Scott L; Getz, Gad; Garraway, Levi A; Schadendorf, Dirk; Dermatologic Cooperative Oncology Group of Germany (DeCOG)
    The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
    In: Cancer Discovery , Jg. 4 2014, Nr. 1, S. 94 – 109
    DOI
  • Goldinger, Simone M; Zimmer, Lisa; Schulz, Carsten; Ugurel, Selma; Hoeller, Christoph; Kaehler, Katharina C; Schadendorf, Dirk; Hassel, Jessica C; Becker, Jürgen; Hauschild, Axel; Dummer, Reinhard
    Upstream mitogen-activated protein kinase (MAPK) pathway inhibition : MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients
    In: European Journal of Cancer (EJC) , Jg. 50 2014, Nr. 2, S. 406 – 410
    DOI
  • Zimmer, Lisa
    23. Jahrestagung der Arbeitsgemeinschaft Dermatologische Onkologie (ADO) - Deutscher Hautkrebskongress in Essen
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 11 2013, Nr. 12, S. 1220 – 1221
    DOI
  • Hermes, I.; Tsiogka, Maria; Rompoti, N.; Suttorp, W.; Zimmer, Lisa; Schadendorf, Dirk
    Autoimmuno-hypophysitis, Autoimmuno-colitis and Autoimmuno-hepatitis in a Patient with metastatic Melanoma during Therapy with CTLA-4 Antibody Ipilimumab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 11 2013, Nr. 9, S. 932
  • Rompoti, Natalia; Schilling, Bastian; Livingstone, Elisabeth; Griewank, Klaus; Hillen, Uwe; Sauerwein, Wolfgang; Pöttgen, Christoph; Stuschke, Martin; Schadendorf, Dirk; Zimmer, Lisa
    Combination of BRAF inhibitors and brain radiotherapy in patients with metastatic melanoma shows minimal acute toxicity
    In: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 30, S. 3844 – 3845
    DOI
  • Griewank, Klaus; Westekemper, Henrike; Schilling, Bastian; Livingstone, Elisabeth; Schimming, Tobias; Sucker, Antje; Hillen, Uwe; Steuhl, Klaus-Peter; Zimmer, Lisa; Schadendorf, Dirk; Steuhl, Klaus-Peter
    Conjunctival Melanomas Harbor BRAF and NRAS Mutations—Response
    In: Clinical Cancer Research , Jg. 19 2013, Nr. 22, S. 6331 – 6332
    DOI
  • Schadendorf, Dirk; Livingstone, Elisabeth; Vaubel, Julia; Zimmer, Lisa
    Hautkrebsforschung reloaded : Paradigmenwechsel in der Dermatoonkologie
    In: Unikate: Berichte aus Forschung und Lehre 2013, Nr. 44: Medizin: 50 Jahre Universitätsklinikum Essen, S. 136 – 143
    DOI, Online Volltext (Open Access)
  • Tsioga, M; Voigtländer, Richard; Suttorp, W; Zimmer, Lisa; Schlamann, Marc; Sure, Ulrich; Lahner, Harald; Moeller, LC; Führer, Dagmar
    Immune-related hypophysitis in three patients with metastatic melanoma undergoing Ipilimumab treatment
    In: Experimental and Clinical Endocrinology & Diabetes , Jg. 121 2013, S. P10
    DOI
  • Gramsch, Carolin; Göricke, Sophia Luise; Behrens, Felix; Zimmer, Lisa; Schadendorf, Dirk; Krasny, Andrej; Forsting, Michael; Schlamann, Marc
    Isolated cerebral susceptibility artefacts in patients with malignant melanoma : Metastasis or not?
    In: European Radiology , Jg. 23 2013, Nr. 9, S. 2622 – 2627
    DOI
  • Rompoti, N.; Schilling, Bastian; Livingstone, Elisabeth; Griewank, Klaus; Hillen, Uwe; Sauerwein, Wolfgang; Pöttgen, Christoph; Stuschke, Martin; Schadendorf, Dirk; Zimmer, Lisa
    Kombination von BRAF-Inhibitoren (BRAFi) und zerebraler Bestrahlung bei Patienten mit metastasiertem Melanom : Eine mögliche Behandlungsoption für neu aufgetretene oder pro-grediente Hirnmetastasen unter Therapie mit BRAF-Inhibitoren
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 11 2013, Nr. 9, S. 952 – 952
  • Schilling, Bastian; Bielefeld, Nicola; Sucker, Antje; Hillen, Uwe; Zimmer, Lisa; Schadendorf, Dirk; Zeschnigk, Michael; Griewank, Klaus
    Lack of SF3B1 R625 mutations in cutaneous melanoma
    In: Diagnostic Pathology , Jg. 8 2013, S. 87
    DOI (Open Access)
  • Griewank, Klaus; Murali, Rajmohan; Schilling, Bastian; Schimming, Tobias; Möller, Inga; Moll, Iris; Schwamborn, Marion; Sucker, Antje; Zimmer, Lisa; Schadendorf, Dirk; Hillen, Uwe
    TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma
    In: PLoS ONE , Jg. 8 2013, Nr. 11, S. e80354
    DOI (Open Access)
  • Griewank, Klaus; Murali, R.; Schilling, Bastian; Scholz, S.; Sucker, A.; Song, M.; Süsskind, D.; Grabellus, Florian; Zimmer, Lisa; Hillen, Uwe; Steuhl, Klaus-Peter; Schadendorf, Dirk; Westekemper, Henrike; Zeschnigk, Michael
    TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
    In: British Journal of Cancer (BJC) , Jg. 109 2013, Nr. 2, S. 497 – 501
    DOI (Open Access)
  • Schadendorf, Dirk; Vaubel, Julia Marianne; Livingstone, Elisabeth; Zimmer, Lisa
    Advances and perspectives in immunotherapy of melanoma
    In: Annals of Oncology , Jg. 23 2012, Nr. Suppl. 10, S. x104 – x108
    DOI
  • Zimmer, Lisa; Hillen, Uwe; Livingstone, Elisabeth; Lacouture, Mario E.; Busam, Klaus; Carvajal, Richard D.; Egberts, Friederike; Hauschild, Axel; Kashani-Sabet, Mohammed; Goldinger, Simone M.; Dummer, Reinhard; Long, Georgina V.; McArthur, Grant; Scherag, Andre; Sucker, Antje; Schadendorf, Dirk
    Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition
    In: Journal of Clinical Oncology (JCO) , Jg. 30 2012, Nr. 19, S. 2375 – 2383
    DOI
  • Livingstone, Elisabeth; Zimmer, Lisa; Vaubel, Julia Marianne; Schadendorf, Dirk
    Current advances and perspectives in the treatment of advanced melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 10 2012, Nr. 5, S. 319 – 325
    DOI
  • Long, Georgina V.; Trefzer, Uwe; Davies, Michael A.; Kefford, Richard F.; Ascierto, Paolo A.; Chapman, Paul B.; Puzanov, Igor; Hauschild, Axel; Robert, Caroline; Algazi, Alain; Mortier, Laurent; Tawbi, Hussein; Wilhelm, Tabea; Zimmer, Lisa; Switzky, Julie; Swann, Suzanne; Martin, Anne-Marie; Guckert, Mary; Goodman, Vicki; Streit, Michael; Kirkwood, John M.; Schadendorf, Dirk
    Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB) : A multicentre, open-label, phase 2 trial
    In: The Lancet Oncology , Jg. 13 2012, Nr. 11, S. 1087 – 1095
    DOI
  • Zimmer, Lisa; Vaubel, Julia Marianne; Schadendorf, Dirk
    Immuntherapie des Melanoms
    In: Der Hautarzt , Jg. 63 2012, Nr. 12, S. 952 – 960
    DOI
  • Zimmer, Lisa; Vaubel, Julia Marianne; Schadendorf, Dirk
    Immuntherapie des Melanoms
    In: Der Onkologe , Jg. 18 2012, Nr. 9, S. 801 – 807
    DOI
  • Zimmer, Lisa; Livingstone, Elisabeth; Rüffer, J.; Jordan, K.
    Nebenwirkungsmanagement von Afatinib
    In: TumorDiagnostik & Therapie , Jg. 33 2012, Nr. 3, S. 154 – 161
    DOI
  • Zimmer, Lisa; Livingstone, Elisabeth; Hillen, Uwe; Dom̈kes, Stephanie; Becker, Arne; Schadendorf, Dirk
    Panniculitis With Arthralgia in Patients With Melanoma Treated With Selective BRAF Inhibitors and Its Management
    In: Archives of Dermatology , Jg. 148 2012, Nr. 3, S. 357 – 361
    DOI
  • Zimmer, Lisa; Vaubel, Julia Marianne; Livingstone, Elisabeth; Schadendorf, Dirk
    Side effects of systemic oncological therapies in dermatology
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 10 2012, Nr. 7, S. 475 – 486
    DOI
  • Livingstone, Elisabeth; Trarbach, Tanja; Zimmer, Lisa; Schuler, Martin; Schadendorf, Dirk
    EGFR-Inhibitoren und Multityrosinkinaseinhibitoren : Interdisziplinäre Behandlung der kutanen Nebenwirkungen
    In: Deutsche Medizinische Wochenschrift - DMW , Jg. 136 2011, Nr. 1-2, S. 39 – 44
    DOI
  • Davey, Martin S.; Tamassia, Nicola; Rossato, Marzia; Bazzoni, Flavia; Calzetti, Federica; Bruderek, Kirsten; Sironi, Marina; Zimmer, Lisa; Bottazzi, Barbara; Mantovani, Alberto; Brandau, Sven; Moser, Bernhard; Eberl, Matthias; Cassatella, Marco A.
    Failure to detect production of IL-10 by activated human neutrophils
    In: Nature Immunology , Jg. 12 2011, Nr. 11, S. 1017 – 1018
    DOI
  • Livingstone, Elisabeth; Zimmer, Lisa; Piel, S.; Schadendorf, Dirk
    PLX4032 : does it keep its promise for metastatic melanoma treatment?
    In: Expert Opinion on Investigational Drugs , Jg. 19 2010, Nr. 11, S. 1439 – 1449
    DOI

    • Abstracts

  • Livingstone, Elisabeth; Forschner, A.; Hassel, J.C.; von Wasielewski, I.; Meier, F.; Mohr, P.; Kähler, K.C.; Schilling, B.; Erdmann, M.; Berking, C.; Huning, S.; Stege, H.; Gutzmer, R.; Kowall, Bernd; Stang, Andreas; Galetzka, W.; Hauschild, A.; Zimmer, Lisa; Schadendorf, Dirk; Lodde, Georg
    Adjuvant treatment of patients with stage III melanoma : 4-year follow-up time of multicenter real-world study
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S740
    DOI
  • Leven, A. S.; Peters, T.; Rajcsanyi, L.S.; Tasdogan, Alpaslan; Placke, Jan-Malte; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Rösch, Alexander; Hinney, Anke; Ugurel, Selma
    Analysis of gender-specific Differences in Response to First-line Treatment with Immunotherapy or targeted Therapy in Melanoma Patients with metastatic Stage IV Melanoma : An ADO/DeCOG Study of 2032 Patients from the prospective, multicenter Skin Cancer Registry ADOREG
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 16 – 17
    DOI
  • Hassel, J.C.; Forschner, A.; Erdmann, M.; Gutzmer, R.; Kähler, K.C.; Holst, I.; Stege, H.; Franklin, C.; Sindrilaru, A.; Zimmer, Lisa; Heinzerling, L.; Utikal, J.; Meier, F.; Berking, C.; Garbe, C.; Weichenthal, M.; Schadendorf, Dirk; Hauschild, A.; Mohr, P.
    Characteristics and quality of life of nine-year survivors from 312 patients with metastatic melanoma treated with pembrolizumab
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S733 – S734
    DOI
  • Becker, Jürgen; Schadendorf, Dirk; Zimmer, Lisa; Ugurel, Selma
    Clinical Characteristics and Survival Data of Patients with advanced Merkel Cell Carcinoma (MCC) treated with Avelumab : Analysis of a prospective German MCC Registry (MCC TRIM)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 11 – 12
    DOI
  • Lodde, Georg; Kowall, Bernd; Stang, Andreas; Galetzka, W.; Zaremba-Montenari, Anne; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Correlation of Laboratory Parameters at the Start of adjuvant Treatment of Stage III Melanoma Patients with clinical Outcome : A multicenter Real World Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 8 – 9
    DOI
  • Tarantino, G.; Zaremba-Montenari, Anne; Vallius, T.; Rambow, F.; Zimmer, Lisa; Sucker, A.; Livingstone, Elisabeth; Hadaschik, Eva; Pelletier, R.; Shi, Y.; Lopez Leon, M.; Makhzami, S.; Lian, C.; Murphy, G.; Sorger, P.; Liu, D.; Schadendorf, Dirk
    Deciphering unresectable in-transit metastasis in melanoma : Multi-modal and longitudinal insights
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S736
    DOI
  • Schadendorf, Dirk; Gogas, H.; Kandolf Sekulovic, L.; Meier, F.; Eigentler, T.K.; Ziemer, M.; Terheyden, P.; Gesierich, A.; Herbst, R.; Kähler, K.C.; Ziogas, D.C.; Mijušković, Ž.; Garzarolli, M.; Garbe, C.; Rösch, Alexander; Ugurel-Becker, Selma; Gutzmer, R.; Grob, J.J.; Zimmer, Lisa; Livingstone, Elisabeth
    Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma : Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology , Jg. 35 2024, Nr. Suppl. 2, S. S1235 – S1236
    DOI
  • Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Lodde, Georg; Tasdogan, Alpaslan; Becker, Jürgen; Griewank, Klaus; Hadaschik, Boris; Schadendorf, Dirk; Ugurel, Selma
    PD-L1 Expression in Lymph Node Metastases as a Predictor of adjuvant Immunotherapy Success in Stage III Melanoma Patients: An Analysis of the prospective ADOREG Study TRIM-ADJUVANT
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 15 – 16
    DOI
  • Zimmer, Lisa
    Survivorship after Skin Cancer Care Situation in Germany, Austria and Switzerland
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 25
    DOI
  • Schielke, L.; Hadaschik, Eva; Lodde, Georg; Albrecht, Jessica Lea; Sucker, A.; Tasdogan, Alpaslan; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Ugurel, Selma; Placke, Jan-Malte
    The PD-L1 Expression predicts the Outcome of anti-PD-1/PD-L1-based Immune Checkpoint Therapy in Patients with metastatic Merkel Cell Carcinoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 17 – 18
    DOI
  • Schaper-Gerhardt, K.; Gutzmer, R.; Angela, Y.; Zimmer, Lisa; Schadendorf, Dirk; Hassel, J. C.; Weishaupt, C.; Remes, B.; Kubat, Linda; Becker, Jürgen C.
    A low interventional trial addressing the immunological effects of the RANKL-inhibitor Denosumab in combination with dual checkpoint blockade in melanoma patients with bone involvement reveals upregulation of CXCL-13
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 17
    DOI (Open Access)
  • Becker, Jürgen C.; Schilling, B.; Leiter-Stoppke, U.; Zimmer, Lisa; Hassel, J.C.; von Wasielewski, I.; Ziemer, M.; Fluck, M.; Meier, F.; Spillner, A.; Gesierich, A.; Eigentler, T.; Livingstone, Elisabeth; Albers, M.; Angela, Y.; Gutzmer, R.
    A single arm phase II, multicenter trial to evaluate the clinical activity and safety of avelumab plus cetuximab in unresectable stage III or IV cutaneous squamous cell carcinoma : First results from the AliCe study
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S654 – S655
    DOI
  • Zillikens, H.; Scheib, C.; Peller, V.; Müller, C.; Bauer, Sebastian; Pretzell, I.; Griewank, Klaus; Sucker, A.; Hadaschik, Eva; Guntrum, F.; Baum, S.H.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Außergewöhnlicher Therapiebenefit von Imatinib bei cKIT-mutiertem Schleimhautmelanom mit nachfolgendem KIT-Mutationsverlust
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 21 – 22
    DOI (Open Access)
  • Placke, Jan-Malte; Kimmig, M.; Griewank, Klaus; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Welzel, J.; Engel, Daniel Robert; Kreft, S.; Sucker, A.; Krefting, F.; Lodde, Georg C.; Stoffels, Ingo; Klode, Joachim; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Hadaschik, Eva; Becker, Jürgen C.; Weichenthal, M.; Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel, Selma
    Die PD-L1-Expression im Tumor prognostiziert je nach Art des untersuchten Gewebes das Outcome einer Anti-PD-1-basierten Immuntherapie bei metastasiertem Melanom
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 27 – 28
    DOI (Open Access)
  • Fischedick, Gerrit; Sahin, Ezgi Ceren; Lübcke, Wolfgang; Gauler, Thomas; Guberina, Maja; Guberina, Nika; Ahmadipour, Yahya; Garcia, Alina Santiago; Zimmer, Lisa; Hense, Jörg; Eberhardt, Wilfried; Stuschke, Martin; Pöttgen, Christoph
    Langzeitergebnisse nach hypofraktionierter ablativer Präzisionsbestrahlung bei Patienten mit multiplen cerebralen Metastasen
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S124
    DOI (Open Access)
  • Jansen, Philipp; Galetzka, W.; Lodde, Georg C.; Zaremba, Anne; Standl, F.; Landsberg, J.; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pföhler, C.; Ulrich, J.; Placke, Jan-Malte; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Weichenthal, M.; Möller, I.; Sucker, A.; Paschen, Annette; Hadaschik, Eva; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Ugurel, Selma; Stang, Andreas; Griewank, Klaus
    Molekulare und klinische Charakterisierung von BRAF/NRAS/NF1-wt Melanomen
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 21
    DOI (Open Access)
  • Lodde, Georg C.; Zhao, F.; Galetzka, W.; Placke, Jan-Malte; Griewank, Klaus; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Weichenthal, M.; Sucker, A.; Paschen, Annette; Horn, S.; Jansen, Philipp; Becker, Jürgen C.; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma
    Untersuchung des klinischen Verlaufs von Melanompatienten mit einer Super-Response (CR/PR innerhalb von 3 Monaten) unter PD-1-basierter Immuncheckpoint-Inhibition : eine Subgruppen-Analyse der prospektiven multizentrischen Studie ADOREG
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 8 – 9
    DOI (Open Access)
  • Becker, Jürgen C.; Ugurel, Selma; Leiter-Stoppke, U.; Meier, F.; Gutzmer, R.; Haferkamp, S.; Zimmer, Lisa; Livingstone, Elisabeth; Eigentler, T.; Hauschild, A.; Kiecker, F.; Hassel, J.C.; Mohr, P.; Fluck, M.; Thomas, I.; Garzarolli, M.; Grimmelmann, I.; Drexler, K.; Eckhardt, S.; Schadendorf, Dirk
    Adjuvant immunotherapy with nivolumab (NIVO) versus observation in completely resected Merkel cell carcinoma (MCC) : Disease-free survival (DFS) results from ADMEC-O, a randomized, open-label phase II trial
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S903
    DOI (Open Access)
  • Schadendorf, Dirk; Hassel, J.C.; Fluck, M.; Eigentler, T.; Loquai, C.; Haferkamp, S.; Gutzmer, R.; Meier, F.; Mohr, P.; Hauschild, A.; Menzer, C.; Kiecker, F.; Dippel, E.; Simon, J-C.; Conrad, B.; Garbe, C.; Körner, S.; Becker, Jürgen C.; Zimmer, Lisa; Livingstone, Elisabeth
    Adjuvant nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma with no evidence of disease (NED) : Overall survival (OS) results of IMMUNED, a randomized, double-blind multi-center phase II DeCOG trial
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S900
    DOI (Open Access)
  • Franklin, Cindy; Mohr, P.; Meier, F.; Lodde, Georg; Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Horn, S.; Schadendorf, Dirk; Ugurel, Selma; et al.
    Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients : a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 13 – 14
    DOI
  • Gutzmer, R.; Weichenthal, M.; Eigentler, T.; Grimmelmann, I.; Sickmann, T.; Zimmer, Lisa; Livingstone, Elisabeth; Ugurel, Selma; Utikal, J. S.; Müller, V.; Göppner, D.; Herbst, R.; Kreuter, A.; Pföhler, C.; Hollburg, W.; Loquai, C.; Kähler, K.; Mohr, P.; Schadendorf, Dirk
    Early safety signals from nivolumab in the adjuvant treatment of real-world melanoma patients derived from the German prospective non-interventional study NICO
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 18 – 19
    DOI
  • Taylor, Amelia M.; Galea, Claire; Lo, Serigne N.; Dimitriou, Florentia; Jacques, Sarah; Allayous, Clara; Yeoh, Hui-Ling; Ressler, Julia M.; Kähler, Katharina C.; Festino, Lucia; Schwarze, Katharina; Wicky, Alexandre M.; Placzke, Joanna; Johnson, Douglas Buckner; Zimmer, Lisa; Lebbe, Celeste; Dummer, Reinhard; Carlino, Matteo S.; Long, Georgina V.; Menzies, Alexander M.
    Efficacy and safety of "second adjuvant" therapy with BRAF/MEK inhibitors after resection of recurrent melanoma following adjuvant PD-1–based immunotherapy
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 9575
    DOI (Open Access)
  • Schadendorf, Dirk; Gogas, Helen; Kandolf Sekulovic, Lidija; Meier, Friedegund Elke; Eigentler, Thomas; Simon, Jan-Christoph; Terheyden, Patrick Andres Maximilian; Gesierich, Anja Heike; Herbst, Rudolf Alexander; Kähler, Katharina C.; Ziogas, Dimitrios C.; Mijuskovic, Zeljko; Garzarolli, Marlene; Garbe, Claus; Rösch, Alexander; Ugurel, Selma; Gutzmer, Ralf; Grob, Jean-Jacques; Zimmer, Lisa; Livingstone, Elisabeth
    Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAFV600-positive melanoma : Interim analysis of the ImmunoCobiVem study
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 9548
    DOI
  • Lai-Kwon, Julia Elizabeth; Jacques, Sarah; Carlino, Matteo S.; Benannoune, Naima; Robert, Caroline; Allayous, Clara; Baroudjian, Barouyr; Lebbe, Celeste; Zimmer, Lisa; Eroglu, Zeynep; Ozturk Topcu, Turkan; Dimitriou, Florentia; Haydon, Andrew Mark; Lo, Serigne N.; Menzies, Alexander M.; Long, Georgina V.
    Efficacy of ipilimumab 3mg/kg following progression on low dose ipilimumab in metastatic melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. e21533
    DOI (Open Access)
  • Albrecht, L. J.; Höwner, A.; Griewank, Klaus; Lueong, S. S.; von Neuhoff, N.; Horn, Peter A.; Sucker, A.; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, S.; Siveke, Jens T.; Schadendorf, Dirk; Váraljai, R.; Rösch, Alexander
    Im Plasma zirkulierende zellfreie mRNA ermöglicht die minimal-invasive und Genotyp-unabhängige Therapieüberwachung bei Patienten mit Melanom
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 12 – 13
    DOI
  • Jehn, B. L.; Waelscher, J.; Wessendorf, Thomas; Livingstone, Elisabeth; Zimmer, Lisa; Metzenmacher, M.; Eberhardt, Wilfried; Theegarten, Dirk; Taube, Christian; Bonella, Francesco
    Immune Checkpoint Inhibitor (ICI)-associated Pulmonary Manifestations (ICI-LM): Characterization of HRCT and BAL Findings
    62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,
    In: Pneumologie , Jg. 76 2022, Nr. Supplement 1, S. S52
    DOI
  • Zaremba, Anne; Meier, F.; Schlein, C.; Jansen, Philipp; Lodde, Georg; Song, M.; Kretz, J.; Möller, I.; Stadtler, N.; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Sucker, A.; Schadendorf, Dirk; Griewank, Klaus
    Klinische und pathologische Merkmale des familiären Melanoms bei Keimbahn-TERT-Promotorvarianten
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 6
    DOI
  • Livingstone, Elisabeth; Forschner, Andrea; Hassel, Jessica Cecile; Wulfken, Lena M.; Meier, Friedegund Elke; Mohr, Peter; Kähler, Katharina C.; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Hüning, Svea; Eckardt, Julia; Gutzmer, Ralf; Reinhardt, Lydia; Kowall, Bernd; Galetzka, Wolfgang; Hauschild, Axel; Zimmer, Lisa; Schadendorf, Dirk; Lodde, Georg
    Multicenter real-world data of adjuvant treatment and disease outcome of patients with melanoma with high-risk of recurrence
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 9570
    DOI (Open Access)
  • Placke, Jan-Malte; Mohr, P.; Bluhm, L.; Engel, Daniel Robert; Franklin, Cindy; Zaremba, Anne; Krefting, F.; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen C.; Tasdogan, Alpaslan; Rösch, Alexander; Schadendorf, Dirk; Ugurel, Selma; et al.
    Predictors of long-term survival of stage IV melanoma patients : a multicenter DeCOG study on 539 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 16 – 17
    DOI
  • Glutsch, V.; Kneitz, H.; Gesierich, A.; Goebeler, M.; Posch, C.; Gebhardt, C.; Haferkamp, S.; Zimmer, Lisa; Becker, Jürgen C.; Leiter-Stöppke, U.; Weichenthal, M.; Schadendorf, Dirk; Ugurel, Selma; Schilling, Bastian
    REINA - Retrospective Multicenter ADOReg Evaluation of Ipilimumab plus Nivolumab in Avelumab-refractory Merkel cell carcinoma
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 21
    DOI
  • Lodde, Georg; Forschner, A.; Hassel, J. C.; Wulfken, L. M.; Meier, F.; Mohr, P.; Kähler, K.; Schilling, Bastian; Loquai, C.; Berking, C.; Hüning, S.; Eckardt, J.; Gutzmer, R.; Reinhardt, L.; Glutsch, V.; Nikfarjam, U.; Erdmann, M.; Kowall, Bernd; Galetzka, W.; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Therapiemanagement des ersten Rezidivs nach adjuvanter Therapie im Stadium III : multizentrische real-world Daten
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 3
    DOI
  • Leiter-Stöppke, U.; Keim, U.; Amaral, T.; Forschner, A.; Berking, C.; Gesierich, A.; Gutzmer, R.; Sunderkötter, C.; Utikal, J. S.; Zimmer, Lisa; Flatz, L.; Garbe, C.
    Which patients should receive adjuvant treatment : an analysis of stage IIA-IIIA patients of the CMMR
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 19
    DOI
  • Pires da Silva, I.; Zakria, D.; Ahmed, T.; Trojaniello, C.; Dimitriou, F.; Allayous, C.; Gerard, C.; Zimmer, Lisa; Lo, S.; Michielin, O.A.; Lebbe, C.; Mangana, J.; Ascierto, P.A.; Johnson, D.; Carlino, M.; Menzies, A.M.; Long, G.V.
    Anti-PD1 (PD1) monotherapy or in combination with ipilimumab (IPI) after BRAF/MEK inhibitors (BRAF/MEKi) in BRAF mutant metastatic melanoma (MM) patients (pts)
    In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. 873 – S874
    DOI (Open Access)
  • Jehn, Lutz-Bernhard; Wälscher, Julia; Wessendorf, Thomas; Livingstone, Elisabeth; Zimmer, Lisa; Metzenmacher, Martin; Eberhardt, Wilfried; Theegarten, Dirk; Bonella, Francesco
    Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP)
    In: European Respiratory Journal (ERJ) 2021, OA4240
    DOI (Open Access)
  • Dimitriou, F.; Namikawa, K.; Teterycz, P.; Reijers, I.L.M.; Buchbinder, E.; Soon, J.; Zimmer, Lisa; Mooradian, M.; Vitale, M.G.; Armstrong, E.; Johnson, D.; Guo, J.; Lebbe, C.; Robert, C.; Mandala, M.; Bhave, P.; Farid, M.; Kähler, K.C.; Lo, S.; Long, G.V.
    Clinical models to predict response in mucosal melanoma (MM) patients (pts) treated with anti-PD-1 (PD1) or combined with ipilimumab (PD1+IPI)
    In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. 877 – S878
    DOI (Open Access)
  • Zaremba, Anne; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa
    Immune checkpoint-Inhibition in Patients with NRAS-mutated Melanoma compared to Patients with NRAS Wild-type Melanoma : Results of a Study on 702 Patients from the prospective, multicenter Registry ADOREG
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 59 – 60
  • Ugurel, Selma; Griewank, Klaus; Horn, S.; Herbst, R.; Terheyden, P.; Utikal, J. S.; Pfoehler, C.; Ulrich, J.; Kreuter, A.; Mohr, P.; Gutzmer, R.; Meier, F.; Dippel, E.; Sucker, A.; Placke, Jan-Malte; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Becker, Jürgen; Weichenthal, M.; Schadendorf, Dirk
    PD-L1-Expression and Mutation Profile in pre-therapeutic Tumor Tissue as Predictors of the Therapeutic Success of PD-1-based Immune Checkpoint Inhibition Therapy in Patients with metastatic Melanoma : Evaluation of the prospective multicentric ADO-Study TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 19
  • Albrecht, L. J.; Grünwald, Viktor; Becker, Jürgen; Gutzmer, R.; Asan, L.; Uslar, E.; Olischewsky, A.; Mueseler, A. C.; Rösch, Alexander; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    PTHrP-induced hypercalcemia Psychosyndrome under Immune Checkpoint Blockade in Patients with penile Squamous Cell Carcinoma
    31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, Hamburg, Germany and Virtual,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 23
    DOI (Open Access)
  • Pires Da Silva, Ines; Versluis, Judith M.; Ahmed, Tasnia; Johnson, Douglas Buckner; Soon, Jennifer; Allayous, Clara; Gerard, Camille Lea; Mangana, Joanna; Klein, Oliver; Zimmer, Lisa; Robert, Caroline; Vitale, Maria Grazia; Yeoh, Hui-Ling; Michielin, Olivier; Lebbe, Celeste; Sandhu, Shahneen Kaur; Blank, Christian U.; Carlino, Matteo S.; Menzies, Alexander M.; Long, Georgina V.
    Patterns and management of progression on first-line ipilimumab combined with anti-PD-1 (IPI+PD1) in metastatic melanoma (MM) patients
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9533 – 9533
    DOI (Open Access)
  • Lodde, Georg; Ugurel, Selma; Placke, Jan-Malte; Griewank, Klaus; Sucker, A.; Jansen, Philipp; Becker, Jürgen; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Schadendorf, Dirk
    Predictors of Super-response (CR/PR within 3 Months) under PD-1-based Immune Checkpoint Inhibition in metastatic Melanoma : A Subgroup Analysis of the prospective multicenter Study ADOREG TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 6 – 7
  • Thielmann, Carl Maximilian; Matull, J.; Zaremba, Anne; Chorti, E.; Lodde, Georg; Jansen, Philipp; Kretz, J.; Möller, I.; Sucker, A.; Paschen, Annette; Livingstone, Elisabeth; Zimmer, Lisa; Hadaschik, Eva; Ugurel, Selma; Schadendorf, Dirk; Griewank, Klaus
    TERT Promoter Mutations associated with longer progression-free and Overall Survival under BRAF/MEK Therapy
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 31
  • Schadendorf, Dirk; Ugurel, Selma; Livingstone, Elisabeth; Zimmer, Lisa
    Termination of targeted Therapy with BRAF-/MEK Inhibitors after an initial complete Response in Patients with metastatic Melanoma and its clinical Implications : A retrospective, multicenter ADOReg Study
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 15 – 16
  • Zimmer, Lisa; Krackhardt, Angela; Schultz, Erwin S.; Goeppner, Daniela; Assaf, Chalid; Trebing, Dietrich; Livingstone, Elisabeth; Schadendorf, Dirk
    Triplet therapy with pembrolizumab (PEM), encorafenib (ENC) and binimetinib (BIN) in advanced, BRAF V600 mutant melanoma : Final results from the dose-finding phase I part of the IMMU-Target trial
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 9532 – 9532
    DOI (Open Access)
  • Placke, Jan-Malte; Soun, C.; Bottek, J.; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, A.; Griewank, Klaus; Horn, S.; Hadaschik, Eva; Rösch, Alexander; Schadendorf, Dirk; Engel, Daniel Robert; Ugurel, Selma
    Tumor PD-L1-Positivity in medical and digital Quantification predicts a favorable Patient Outcome for a PD-1-based Immune Checkpoint-Blockade in metastatic Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 58 – 59
  • Zaremba, Anne; Martaki, Anna; Salzmann, Martin; Baroudjian, Barouyr; Sachse, Michael M.; Gesierich, A.; Reinhardt, Lydia; Meier, F.; Hassel, Jessica C.; Ugurel, Selma; Rösch, Alexander; Schadendorf, Dirk; Livingstone, Elisabeth; Broeckelmann, Paul; Kramer, R.; Heinzerling, L.; Zimmer, Lisa
    Agranulozytose unter Immuncheckpoint‐Blockade : Eine retrospektive, multizentrische Auswertung
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV28
    DOI (Open Access)
  • Placke, Jan-Malte; Rawitzer, J.; Reis, Henning; Livingstone, Elisabeth; Ugurel, Selma; Hadaschik, Eva; Schmid, Kurt Werner; Rösch, Alexander; Zimmer, Lisa
    Apoptotische Gastritis nach Immuncheckpointblockade : Ein typisches histopathologisches Muster
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P12
    DOI (Open Access)
  • Rogiers, Aljosja; Tondini, Carlo; Grimes, Joe M.; Zimmer, Lisa; Long, Georgina V.; et al.
    Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI)
    Annual Meeting of the American Association for Cancer Research (AACR), COVID-19 and Cancer, July 20-22, 2020, Virtual,
    In: Clinical Cancer Research , Jg. 26 2020, Nr. 18 Suppl., S. 02 – 01
    DOI (Open Access)
  • Owen, C.N.; Bai, X.; Quah, T.; Lo, Serigne; Callaghan, S.; Martínez-Vila, C.; Bhave, P.; Reijers, I.; Gerard, C.L.; Aspelagh, S.; Xu, W.; Welsh, S.J.; Sandhu, S.; Mangana, Johanna; McQuade; Ascierto, Paolo A.; Zimmer, Lisa; Johnson, Douglas B.; Lebbé, C.; Menzies, Alexander M.
    Delayed immune-related adverse events (irAEs) on anti-PD1-based therapy
    In: Annals of Oncology , Jg. 31 2020, Nr. Suppl. 4, S. S761 – S762
    DOI (Open Access)
  • Placke, Jan-Malte; Ugurel, Selma; Lodde, Georg; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Schadendorf, Dirk; Funke-Lorenz, Carolin
    Die Extracorporale Photopherese verbessert therapierefraktäre autoimmune Nebenwirkungen nach Immuncheckpointblockade
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV06
    DOI (Open Access)
  • Franklin, Cindy; Wetter, Axel; Baba, Hideo Andreas; Cosgarea, Ioana; Mauch, Cornelia; Livingstone, Elisabeth; Zimmer, Lisa; Schadendorf, Dirk; Ugurel, Selma
    Die diagnostische Bedeutung der CT-gesteuerten Punktion bei Hauttumorpatienten
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV49
    DOI (Open Access)
  • Placke, Jan-Malte; Soun, Camille; Bottek, Jenny; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pfoehler, Claudia; Ulrich, Jens; Kreuter, Alexander; Pfeiffer, Constance M.; Mohr, Peter; Gutzmer, Ralf; Meier, F.; Dippel, Edgar; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Lodde, Georg; Sucker, Antje; Griewank, Klaus; Horn, Susanne; Hadaschik, Eva; Rösch, Alexander; Engel, Daniel Robert; Schadendorf, Dirk; Ugurel, Selma
    Die digitale Analyse der Tumor PD‐L1 Expression ist ein guter Prädiktor des Therapieerfolgs einer anti‐PD1‐basierten Immuntherapie : Eine Subgruppenanalyse der multizentrischen translationalen Studie ADOREG/TRIM
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV36
    DOI (Open Access)
  • Lodde, Georg; Ruebben, Albert; Zimmer, Lisa; Livingstone, Elisabeth; Becker, Jürgen; Placke, Jan-Malte; Griewank, Klaus; Hadaschik, Eva; Schadendorf, Dirk; Ugurel, Selma
    Eindrucksvolles und schnelles Therapieansprechen eines metastasierten Adnexkarzinoms unter Cemiplimab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV08
    DOI (Open Access)
  • Spassova, Ivelina; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Terheyden, Patrick; Andtback, H. B.; Villabona, Luis; Leiter-Stoeppke, Ulrike; Eigentler, Thomas K.; Loquai, Carmen; Hassel, Jessica C.; Gambichler, Thilo; Haferkamp, Sebastian; Mohr, Peter; Pfoehler, Claudia; Heinzerling, L.; Horny, Kai; Habermann, Dirk; Hoffmann, D.; Becker, Jürgen
    Immun‐Checkpoint‐Blockade beim Merkelzellkarzinom : Klinische und molekulare Biomarker‐Analyse
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV22
    DOI (Open Access)
  • Pires Da Silva, Ines; Ahmed, Tasnia; Lo, Serigne; Reijers, Irene L.M.; Weppler, Alison; Betof Warner, Allison; Patrinely, James Randall; Serra-Bellver, Patricio; Lebbe, Celeste; Mangana, Joanna; Nguyen, Khang; Zimmer, Lisa; Ascierto, Paolo Antonio; Stout, Dan; Lyle, Megan; Klein, Oliver; Gerard, Camille Lea; Blank, Christian U.; Menzies, Alexander M.; Long, Georgina V.
    Ipilimumab (IPI) alone or in combination with anti-PD-1 (IPI+PD1) in patients (pts) with metastatic melanoma (MM) resistant to PD1 monotherapy
    In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 15_Suppl., S. 10005
    DOI (Open Access)
  • Bhave, Prachi; Pallan, Lalit; Atkinson, Victoria; Cohen, Justine Vanessa; Chiarion-Sileni, Vanna; Nyakas, Marta; Kaehler, Katharina C.; Plummer, Elizabeth; Ascierto, Paolo Antonio; Zimmer, Lisa; Lebbe, Celeste; Maurichi, Andrea; Robert, Caroline; Lesimple, Thierry; Patel, Sapna Pradyuman; Versluis, Judith M.; Khattak, Muhammad Adnan; Van Der Westhuizen, Andre; Carlino, Matteo S.; Haydon, Andrew Mark
    Melanoma recurrence after adjuvant targeted therapy : A multicenter analysis
    In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 15_Suppl., S. 10016
    DOI (Open Access)
  • Olischewsky, Alexandra; Schneider, M.; Koch, Fiona; Lodde, Georg; Alt, Clemens; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Neoadjuvante Immun‐ und zielgerichtete Therapie bei Melanompatienten im Stadium III B
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV44
    DOI (Open Access)
  • Salzmann, Martin; Leiter-Stoeppke, Ulrike; Loquai, Carmen; Zimmer, Lisa; Ugurel, Selma; Gutzmer, Ralf; Thoms, Kai-Martin; Hassel, Jessica C.
    PD1‐Inhibitoren bei fortgeschrittenem kutanem Plattenepithelkarzinom : „Real World“‐Daten einer retrospektiven, multizentrischen Studie
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV20
    DOI (Open Access)
  • Michel, Lars; Hendgen-Cotta, Ulrike B.; Mincu, Raluca I.; Helfrich, Iris; Korste, S; Mrotzek, Simone; Rischpler, C; Herrmann, Ken; Ugurel, Selma; Zimmer, Lisa; Coman, C; Ahrends, R; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias
    Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
    ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,
    In: European Heart Journal , Jg. 41 2020, Nr. Supplement_2, S. 3260
    DOI (Open Access)
  • Kramer, R.; Mentzer, Debra; Erdmann, Michael; Knauss, Sharon; Broeckelmann, Paul J.; Hassel, Jessica C.; Ugurel, Selma; Pavel, Moraru; Nickel, Florian T.; Landendinger, Melanie; Fuchs, Franca; Meidenbauer, Norbert; Jefremow, Andre; Manger, Bruce S.; Gutzmer, Ralf; Loquai, Carmen; Kaehler, Katharina C.; Zimmer, Lisa; Berking, Carola; Keller-Stanislawski, Brigitte; Heinzerling, L.
    SERIO – Side Effect Registry Immuno‐Oncology : Nebenwirkungsregister für seltene, schwere und komplexe Nebenwirkungen von Immuntherapien
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV27
    DOI (Open Access)
  • Hepner, Adriana; Versluis, Judith M.; Gerard, Camille Lea; Brown, Lauren Julia; Wallace, Roslyn; Bhave, Prachi; Jansen, Yanina; Klein, Oliver; Warner, Allison Betof; Mangana, Joanna; Atkinson, Victoria; Lo, Serigne; Long, Georgina V.; Johnson, Douglas Buckner; McQuade, Jennifer Leigh; Ascierto, Paolo Antonio; Zimmer, Lisa; Lebbe, Celeste; Blank, Christian U.; Menzies, Alexander M.
    The nature and management of acquired resistance to PD1-based therapy in melanoma
    In: Journal of Clinical Oncology (JCO) , Jg. 38 2020, Nr. 15_Suppl., S. 10014
    DOI (Open Access)
  • Versluis, J.M.; Hendriks, A.M.; Weppler, A.; Brown, L.; de Joode, K.; Suijkerbuijk, Karijn P. M.; Zimmer, Lisa; Kapiteijn, E.; Allayous, C.; Johnson, Douglas B.; Hepner, A.; Mangana, Johanna; Bhave, P.; Jansen, Y.; Trojaniello, C.; Atkinson, Victoria; Storey, L.; de Vries, Elisabeth G. E.; Blank, C.U.; Jalving, Mathilde
    The value of local therapy in treatment of solitary melanoma progression upon immune checkpoint inhibition
    In: Annals of Oncology , Jg. 31 2020, Nr. Suppl. 4, S. S733 – S734
    DOI (Open Access)
  • Lodde, Georg; Forschner, Andrea; Wulfken, Lena M.; Meier, F.; Mohr, Peter; Kaehler, Katharina C.; Schilling, Bastian; Loquai, Carmen; Berking, Carola; Gebhardt, C.; Huening, Svea; Schatton, Kerstin; Eckardt, Josephine; Gutzmer, Ralf; Reinhardt, Lydia; Glutsch, Valerie; Nikfarjam, Ulrike; Erdmann, Michael; Stang, Alexander; Ugurel, Selma; Zimmer, Lisa; Schadendorf, Dirk; Livingstone, Elisabeth
    Therapieentscheidung bei Indikation zur adjuvanten Therapie des Melanoms : Multizentrische Real World Data
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 18 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV43
    DOI (Open Access)
  • Puig-Butille, J. A.; Potrony, M.; Gimenez-Xavier, P.; Tell-Marti, G.; Rebollo-Morell, A.; Zimmer, Lisa; Carreras, E.; Aranda, F.; Sucker, A.; Schadendorf, Dirk
    Variants in CD5 and IRF4 impact into melanoma survival
    In: European Journal of Human Genetics , Jg. 26 2019, Nr. Suppl., S. 688 – 689
    DOI (Open Access)
  • Becker, Jürgen; Hassel, Jessica Cecile; Menzer, Christian; Kahler, Katharina C.; Eigentler, Thomas K.; Meier, Friedegund Elke; Berking, Carola; Gutzmer, Ralf; Mohr, Peter; Kiecker, Felix; Kaatz, Martin; Windemuth-Kieselbach, Christiane; Lorenz-Schlüter, Claudia; Zimmer, Lisa; Ugurel, Selma; Schadendorf, Dirk
    Adjuvant ipilimumab compared with observation in completely resected Merkel cell carcinoma (ADMEC) : A randomized, multicenter DeCOG/ADO study
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 9527
    DOI (Open Access)
  • Becker, Jürgen; Hassel, J.; Menzer, C.; Hauschild, A.; Eigentler, T.; Meier, F.; Berking, C.; Gutzmer, R.; Mohr, P.; Kiecker, F.; Kaatz, M.; Windemuth‐Kieselbach, C.; Lorenz‐Schlüter, C.; Zimmer, Lisa; Ugurel, Selma; Schadendorf, Dirk; German Dermatooncology Group (DeCOG/ADO)
    Adjuvante Therapie des Merkelzellkarzinoms mit Ipilimumab im Vergleich zur Beobachtung (ADMEC) : eine randomisierte, multizentrische ADO‐Studie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 6
    DOI (Open Access)
  • Kanaki, T.; Knispel, Sarah; Chorti, E.; Albrecht, M.; Martaki, A.; Zaremba, Anne; Sucker, A.; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Auswirkungen der überarbeiteten AJCC‐Klassifikation (8. Edition) auf das Essener Melanomkollektiv
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 61 – 62
    DOI (Open Access)
  • Placke, Jan-Malte; Knispel, Sarah; Chorti, E.; Albrecht, M.; Kanaki, T.; Jockenhöfer, Finja; Martaki, A.; Zaremba, Anne; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Autoimmunbedingte Gastritis nach Immuncheckpoint‐Blockade : eine Fallserie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 26 – 27
    DOI (Open Access)
  • Hassel, Jessica Cecile; Menzer, Christian; Menzies, Alexander M.; Carlino, Matteo S.; Long, Georgina V.; Kefford, Richard; Eigentler, Thomas K.; Johnson, Douglas Buckner; Schlaak, Max; Meiss, Frank; Schilling, Bastian; Gutzmer, Ralf; Pföhler, Claudia; Meier, Friedegund Elke; Zimmer, Lisa; Haalck, Thomas; Thoms, Kai; Kopp-Schneider, Annette; Enk, Alexander
    BRAF/MEK inhibition in melanoma patients with rare BRAF mutations
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 9542 – 9542
    DOI (Open Access)
  • Kubat, L.; Schrama, D.; Melior, Anita; Herbst, R.; Terheyden, P.; Utikal, J.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Pfeiffer, C.; Mohr, P.; Gutzmer, R.; Schilling, Bastian; Sucker, A.; Meier, F.; Dippel, E.; Kaatz, M.; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Becker, Jürgen
    CCR5 Δ32 Polymorphismus als prädiktiver Marker für die Therapie mit Immuncheckpoint‐Inhibitoren beim Melanom
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 49 – 50
    DOI (Open Access)
  • Satzger, I.; Momma, M.; Thoms, K. M.; Eigentler, T.; Loquai, C.; Zimmer, Lisa; Heinzerling, L.; Kähler, K.; Herbst, R.; Utikal, J.; Hassel, J.; Meier, F.; Pföhler, C.; Ruini, C.; Gutzmer, R.
    Charakterisierung des Checkpoint‐Inhibitor‐assoziierten Diabetes mellitus – Erfahrungen bei 12 Patienten
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 15 – 16
    DOI (Open Access)
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Bauer, Sebastian; Podleska, Lars; Schulz, A.; Schimming, Tobias; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth
    Clear Cell Sarcoma - a rare Differential Diagnosis of malignant Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. Suppl. 6, S. 3
  • Ugurel, Selma; Horn, S.; Griewank, Klaus; Sucker, A.; Herbst, R.; Terheyden, P.; Utikal, J.; Pföhler, C.; Ulrich, J.; Kreuter, A.; Pfeiffer, C.; Mohr, P.; Gutzmer, R.; Weyandt, G.; Meier, F.; Dippel, E.; Kaatz, M.; Weichenthal, M.; Schilling, Bastian; Becker, Jürgen; Zimmer, Lisa; Livingstone, Elisabeth; Rebmann, Vera; Schadendorf, Dirk
    Die Anzahl mutierter Melanom‐assoziierter Gene und die Expression von PD‐L1 sind unabhängige Prädiktoren der anti‐PD1 Immuntherapie ‐ eine prospektive Registerstudie der ADO (ADOREG/TRIM)
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 7 – 8
    DOI (Open Access)
  • Knispel, Sarah; Zimmer, Lisa; Gutzmer, R.; Heinzerling, L.; Weishaupt, C.; Pföhler, C.; Gesierich, A.; Herbst, R.; Kähler, K.; Weide, B.; Schlaak, M.; Loquai, C.; Utikal, J.; Terheyden, P.; Kaatz, M.; Berking, C.; Kreuter, A.; Ulrich, J.; Mohr, P.; Dippel, E.; Weichenthal, M.; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma
    Einfluss einer vorangegangenen Radiatio auf den Erfolg einer immunonkologischen Therapie beim metastasierten Melanom – eine retrospektive multizentrische Studie der ADO
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 28 – 29
    DOI (Open Access)
  • Dearden, Helen Clare; Au, Lewis; Wang, Daniel Ying; Zimmer, Lisa; Eroglu, Zeynep; Smith, Jessica Louise; Curvietto, Marcello; Khoo, Chloe; Atkinson, Victoria; Lo, Serigne; Guminski, Alexander; Long, Georgina V.; Sandhu, Shahneen Kaur; Ascierto, Paolo Antonio; Carlino, Matteo S.; Johnson, Douglas Buckner; Larkin, James M. G.; Menzies, Alexander M.
    Hyperacute toxicity with combination ipilimumab (ipi) and anti-PD1 immunotherapy
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. 9545 – 9545
    DOI (Open Access)
  • Mitzel‐Rink, H.; Hassel, J.; Berking, C.; Gutzmer, R.; Heinzerling, L.; Majenka, P.; Meier, F.; Moreira, A.; Terheyden, P.; Thoms, K. M.; Tietze, J.; Zimmer, Lisa; Kähler, K.; Loquai, C.
    Hyponatriämie und Nephritis – seltene Nebenwirkungen von Checkpointinhibitoren bei Patienten mit metastasiertem Melanom
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 15
    DOI (Open Access)
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Bauer, Sebastian; Podleska, Lars; Schulz, Andrea; Schimming, T.; Hadaschik, Eva; Griewank, Klaus; Schadendorf, Dirk; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth
    Klarzellsarkom – eine seltene Differentialdiagnose des malignen Melanoms
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 3
    DOI (Open Access)
  • Chorti, E.; Keyvani, Kathy; Umutlu, Lale; Kanaki, T.; Zaremba, Anne; Jockenhöfer, Finja; Knispel, Sarah; Placke, Jan-Malte; Albrecht, M.; Martaki, A.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Glas, M.; Zimmer, Lisa
    Meningeosis melanomatosa : Schlechte Prognose trotz neuer Systemtherapeutika
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 11 – 12
    DOI (Open Access)
  • Hensen, J.; Thoms, K. M.; Kähler, K.; Gutzmer, R.; Zimmer, Lisa; Zacher, M.; Alter, M.; Loquai, C.; Moreira, A.; Hassel, J.; Utikal, J.
    Mundtrockenheit unter Immuncheckpoint‐Inhibitoren: eine Analyse von 29 Patienten aus 10 deutschen Hautkrebszentren
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 10 – 11
    DOI (Open Access)
  • Gutzmer, R.; Eigentler, T.; Mohr, P.; Becker, S.; Haferkamp, S.; Meiß, F.; Pföhler, C.; Satzger, I.; Schneider, S. W.; Terheyden, P.; Ulrich, J.; Utikal, J.; Weichenthal, M.; Weishaupt, C.; Zimmer, Lisa; Schadendorf, Dirk
    NICO ‐ eine nationale, prospektive, nicht‐interventionelle Studie (NIS) mit Nivolumab als Monotherapie oder in Kombination mit Ipilimumab bei Patienten mit fortgeschrittenem (inoperablem oder metastasiertem) Melanom zur Erhebung von real‐world data
    Konferenz 28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 79
    DOI (Open Access)
  • Moreira, A.; Loquai, C.; Knauss, S.; Gutzmer, R.; Dimitriou, F.; Meier, F.; Heppt, M.; Mitzel‐Rink, H.; Schuler, G.; Terheyden, P.; Thoms, K. M.; Zimmer, Lisa; Dummer, R.; Pföhler, C.; Heinzerling, L.
    Neuromuskuläre Nebenwirkungen von Immuncheckpoint‐Inhibitoren
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 9 – 10
    DOI (Open Access)
  • Zaremba, Anne; Chorti, E.; Jockenhöfer, Finja; Albrecht, M.; Placke, Jan-Malte; Knispel, Sarah; Schadendorf, Dirk; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth
    Partielle Remission eines fortgeschrittenen Melanoms durch eine Kombinationstherapie mit Nivolumab und Trametinib nach Therapieversagen unter Ipilimumab + Nivolumab
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 38
    DOI (Open Access)
  • Eigentler, T.; Gutzmer, R.; Mohr, P.; Kaatz, M.; Pföhler, C.; Terheyden, P.; Ulrich, J.; Utikal, J.; Zimmer, Lisa; Schadendorf, Dirk
    Real-world evidence in melanoma : A national, prospective, non-interventional study (NIS) of nivolumab monotherapy or in combination with ipilimumab in patients with advanced (unresected or metastatic) melanoma (NICO)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 1, S. 159
    DOI (Open Access)
  • Kolblinger, Peter; Cohen, Justine Vanessa; Buchbinder, Elizabeth Iannotti; Eroglu, Zeynep; Hassel, Jessica Cecile; Gesierich, Anja; Goldinger, Simone M.; Hoeller, Christoph; Zimmer, Lisa; McKean, Meredith Ann; Menzies, Alexander M.; Rozeman, Elisa A.; Gutzmer, Ralf; Forschner, Andrea; Johnson, Douglas Buckner; Ascierto, Paolo Antonio; Lo, Serigne; Khoo, Chloe Chia Hoey; Dummer, Reinhard; Benannoune, Naima
    The utility of chemotherapy after immunotherapy failure in metastatic melanoma : A multicenter case series.
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. 15 Suppl., S. e21588
    DOI (Open Access)
  • Bischof, L.; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Hadaschik, Eva; Becker, Jürgen; Schadendorf, Dirk; Ugurel, Selma
    Therapieversagen der Immuncheckpoint‐Blockade mit PD1‐Antikörpern bei Patienten mit metastasierten Hauttumorerkrankungen und gleichzeitiger Immunsuppression durch eine Chronisch Lymphatische Leukämie
    28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 16 2018, Nr. S6, S. 28
    DOI (Open Access)
  • Chorti, E.; Tiedje, Vera; Zaremba, Anne; Jockenhöfer, Finja; Hoge, J.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Führer, Dagmar; Livingstone, Elisabeth; Zimmer, Lisa
    Diagnostik und Therapie der immunvermittelten Thyreoiditis unter Therapie mit Ipilimumab und Nivolumab
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 15 2017, Nr. Suppl. 3, S. 26 – 27
    DOI
  • Zimmer, Lisa; Eigentler, Thomas K.; Vaubel, Julia Marianne; Mohr, Peter; Jradi, Zeinab; Kiecker, Felix; Utikal, Jochen; Berking, Carola; Kämpgen, Eckhart; Hauschild, Axel; Dippel, Edgar; Rompel, Rainer; Fluck, Michael; Stadler, Rudolf; Herbst, Rudolf; Terheyden, Patrick; Garbe, Claus; Loquai, Carmen; Schadendorf, Dirk
    Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, Suppl., S. 9031
    DOI

    • Poster / Posterbeiträge

  • Albrecht, L. J.; Dimitriou, F.; Grover, P.; Hassel, J. C.; Erdmann, M.; Forschner, A.; Johnson, D.; Livingstone, Elisabeth; Rösch, Alexander; Ugurel, Selma; Schulz, C.; Berking, C.; Menzies, A. M.; Long, G. V.; Dummer, R.; Schadendorf, Dirk; Zimmer, Lisa
    Anti-PD1 plus BRAF/MEK inhibitors (triplet therapy) after failure of standard therapy in patients (pts) with advanced melanoma
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 44
    DOI (Open Access)
  • Scheib, C.; Zillikens, H.; Peller, V.; Müller, C.; Rudolph, V.; Leven, A. S.; Griewank, Klaus; Sucker, A.; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Ausgedehntes Rezidiv eines atypischen Fibroxanthoms
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO-Jahrestagung) 06.–09. September 2023 Hamburg, S. 99
    DOI (Open Access)
  • Becker, Jürgen C.; Mahmoudpour, S.; Schadendorf, Dirk; Leiter-Stoppke, U.; Meier, F.; Herbst, R.; Sachse, M.; Grabbe, S.; Gebhardt, C.; Ziller, F.; Pfoehler, C.; Mohr, P.; Zimmer, Lisa; Boutmy, E.; Hoff, S.; Verpillat, P.; Fernandez Milano, A.; Shlaen, M.; Fu, C.; Ugurel-Becker, Selma
    Clinical characteristics and survival of patients with advanced Merkel cell carcinoma (MCC) treated with avelumab : Analysis of a prospective German MCC registry (MCC TRIM)
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S685 – S686
    DOI
  • Rudolph, V.; Leven, A. S.; Peller, V.; Müller, C.; Scheib, C.; Zillikens, H.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Langfristiger Therapieerfolg von sequentieller Immun- und zielgerichteter Therapie beim metastasierten malignen Melanom
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 47 – 48
    DOI (Open Access)
  • Lodde, Georg C.; Dollani, J.; Galetzka, W.; Stang, Andreas; Ugurel, Selma; Rösch, Alexander; Zaremba, Anne; Sucker, A.; Zimmer, Lisa; Schadendorf, Dirk; Griewank, Klaus; Livingstone, Elisabeth
    Melanom mit unbekanntem Primarius (MUP) - eine monozentrische Auswertung
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 76 – 77
    DOI (Open Access)
  • Tarantino, G.; Zaremba, Anne; Vallius, T.; Rambow, F.; Zimmer, Lisa; Sucker, A.; Livingstone, Elisabeth; Pelletier, R.; Makhzami, S.; Murphy, G.; Lian, C.; Sorger, P.; Liu, D.; Schadendorf, Dirk
    Multi-modal and longitudinal characterization of the tumor and immune microenvironment from primary melanoma to in-transit and distant metastasis
    ESMO Congress 2023 ; 20 - 24 October 2023 Madrid, Spain,
    In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S694
    DOI (Open Access)
  • Müller, C.; Scheib, C.; Peller, V.; Zillikens, H.; Rudolph, V.; Leven, A. S.; Bauer, Sebastian; Pretzell, I.; Griewank, Klaus; Sucker, A.; Hadaschik, Eva; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Therapieansprechen auf Sunitinib bei Imatinib-resistentem Rezidiv eines Dermatofibrosarkoma protuberans am Capillitium
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 99 – 100
    DOI (Open Access)
  • Peller, V.; Müller, C.; Zillikens, H.; Scheib, C.; Viktoria, R.; Rösch, Alexander; Ugurel, Selma; Becker, Jürgen C.; Gutzmer, R.; Schadendorf, Dirk; Livingstone, Elisabeth; Zimmer, Lisa
    Therapieoption beim lokal fortgeschrittenen kutanen Plattenepithelkarzinom nach Cemiplimab-Resistenz
    33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 72
    DOI (Open Access)
  • Zaremba, Anne; Jansen, Philipp; Murali, R.; Mayakonda, A.; Riedel, A.; Krahl, D.; Burkhardt, H.; John, S.; Géraud, C.; Philip, M.; Kretz, J.; Möller, I.; Stadtler, N.; Sucker, A.; Paschen, Annette; Ugurel, Selma; Zimmer, Lisa; Livingstone, Elisabeth; Horn, S.; Plass, C.; Schadendorf, Dirk; Hadaschik, Eva; Lutsik, P.; Griewank, Klaus
    Genetic and methylation analysis of CTNNB1 mutations in benign and malignant melanocytic lesions
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 84
    DOI
  • Franklin, Cindy; Mohr, P.; Bluhm, L.; Rösch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, S.; Ugurel, Selma; et al.
    Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis : a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 29 – 30
    DOI
  • Harvey, Catriona; Nahar, Kazi Jannatun; Lo, Serigne N.; Ahmed, Tasnia; Farag, Sheima; Yousaf, Nadia; Young, Kate; Tas, Liselotte; Meerveld-Eggink, Aafke; Blank, Christian U.; Thomas, Austin; McQuade, Jennifer Leigh; Schilling, Bastian; Johnson, Douglas Buckner; Martin Huertas, Roberto; Arance, Ana Maria; Lee, Joanna; Zimmer, Lisa; Long, Georgina V.; Menzies, Alexander M.
    Management of infliximab-refractory immune checkpoint inhibitor gastrointestinal toxicity : A multicenter case series
    2022 Annual Meeting of the American Society of Clinical Oncology (ASCO) ; June 3-7, 2022, Chicago, Ill., USA and virtual,
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl.: 2022 ASCO Annual Meeting, S. 2665
    DOI (Open Access)
  • Jansen, P.; Zaremba, Anne; Philip, M.; Lodde, Georg; Livingstone, Elisabeth; Zimmer, Lisa; Ugurel, Selma; Paschen, Annette; Sucker, A.; Möller, I.; Landsberg, J.; Rose, C.; Emberger, M.; Schaller, J.; Plass, C.; Hadaschik, Eva; Schadendorf, Dirk; Mentzel, T.; Lutsik, P.; Griewank, Klaus
    Molekularpathologie und Methylierungsprofile als diagnostische Unterstützung zur Differenzierung von Klarzellsarkomen und melanozytären Tumoren
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 88
    DOI
  • Kreft, S.; Richter, L.; Peller, V.; Rieß, V.; Albrecht, L. J.; Müseler, A. C.; Rösch, Alexander; Ugurel, Selma; Schadendorf, Dirk; Zimmer, Lisa; Livingstone, Elisabeth
    Partielle Remission auf Cemiplimab eines beidseitig Orbitae-infiltrierenden Basalzellkarzinoms des Mittelgesichts
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 44 – 45
    DOI
  • Mo, J.; Zaremba, Anne; Inderjeeth, A-J.; El Zenaity, P.; Li, A.; Wicky, A.; Della Marta, N.; Gaudy Marqueste, C.; Bohne, A-S.; Festino, L.; Chen, C.; Lo, S.N.; Guminski, A.; Michielin, O.A.; Xu, W.; Lebbe, C.; Sandhu, S.K.; Zimmer, Lisa; Carlino, M.S.; Pires da Silva, I.
    Patterns of response/progression and management following progressive disease (PD) with anti-PD-(L)1 (PD(L)1) in patients (pts) with advanced Merkel cell carcinoma (MCC)
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S924 – S925
    DOI (Open Access)
  • Salzmann, M.; Wald, A.; Stege, H.; Loquai, C.; Zimmer, Lisa; Hayani, K.; Heinzerling, L.; Gutzmer, R.; Enk, A.; Hassel, J. C.
    Tolerability and efficacy of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch : a multicenter, retrospective study
    32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 28 – 29
    DOI
  • Zaremba, Anne; Ferdinandus, J.; Zimmer, Lisa; Umutlu, Lale; Seifert, R.; Barbato, F.; Ugurel, Selma; Chorti, E.; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth
    Additional Benefit of FDG-PET when Discontinuing Immune Checkpoint Inhibitor Therapy in Patients with metastatic Melanoma
    31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, Hamburg, Germany and Virtual,
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 19 2021, Nr. Suppl. 4, S. 75 – 76
    DOI (Open Access)